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(1) General Information 
Except where stated, all reagents were purchased from commercial sources and used without further 
purification. Except where stated, all experimental procedures were carried out under an atmosphere of 
argon. Anhydrous CH2Cl2 and toluene were obtained from an Innovative Inc. PureSolv
® solvent 
purification system. Anhydrous THF was obtained by distillation over sodium benzophenone ketyl 
immediately before use. Chloroform was used as supplied without additional drying. 1H NMR and 13C 
NMR spectra were recorded on a JEOL ECX400 or JEOL ECS400 spectrometer, operating at 400 MHz 
and 100 MHz, respectively. All spectral data were acquired at 295 K. Chemical shifts (δ) are quoted in 
parts per million (ppm). The residual solvent peaks, δH 7.26 and δC 77.0 for CDCl3 and δH 2.50 and δC 39.5 
for DMSO-d6 were used as a reference. Coupling constants (J) are reported in Hertz (Hz) to the nearest 
0.5 Hz. The multiplicity abbreviations used are: s singlet, d doublet, t triplet, q quartet, m multiplet. 
Signal assignment was achieved by analysis of DEPT, COSY, NOESY, HMBC and HSQC experiments 
where required. Infrared (IR) spectra were recorded on a PerkinElmer UATR two spectrometer as a thin 
film. Mass-spectra (low and high-resolution) were obtained by the University of York Mass Spectrometry 
Servive, using electrospray ionisation (ESI) on a Bruker Daltonics, Micro-TOF spectrometer. The melting 
points were determined using Gallenkamp apparatus and are uncorrected. Thin layer chromatography was 
carried out on Merck silica gel 60F254 pre-coated aluminium foil sheets and were visualised using UV 
light (254 nm) and stained with either basic aqueous potassium permanganate or ethanolic p-anisaldehyde 
as appropriate. Flash column chromatography was carried out using slurry packed silica gel (SiO2), 35-75 
µm particle size, 60 Å pore size, under a light positive pressure, eluting with the specified solvent system. 
Petrol refers to petroleum ether 40–60 °C. Microwave experiments were carried out using sealed vessels 
in a CEM Discover microwave reactor with variable power output (0-200 W). Pressure was recorded by 
the cavity lid, which resisted the deformation of the vial cap as pressure increased.  
 
(2) Literature procedures for the preparation of indole acid and imine substrates 
 
Acids 5a and 5g are commercially available and were used as supplied. Acids 5c1 and 5h2 and imines 










(3)  General procedures  
 
General Procedure A: Spirocycle synthesis from N-acyliminium ions 
DIPEA (1.85 eq, 245 μL, 1.41 mmol) and T3P (1.5 eq, 725 mg of a 50% w/v solution in THF, 1.14 mmol) 
were added to a stirred solution of imine (1 eq, 0.762 mmol) and acid (1.2 eq, 0.909 mmol) in solvent (4 
mL) at a specified temperature. The resulting solution was stirred in a sealed vessel for a specified time. 
The solution was diluted with CH2Cl2 (10 mL) and poured into sat. NaHCO3(aq) (10 mL). The two layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organics 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
 
General Procedure B: NaBH4 reduction of spirocyclic indolenine 
NaBH4 (4 eq, 1.32 mmol) was added portionwise (CARE: effervescence) to a stirred solution of imine (1 
eq, 0.33 mmol) in MeOH (5 mL) at 0 °C under Ar. The reaction mixture was heated to reflux and stirred 
for 3.5 h and then allowed to cool to rt. The solvent was evaporated under reduced pressure and the 
resulting residue taken up in H2O (10 mL) and CH2Cl2 (10 mL). The two layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organics were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product.  
 
General Procedure C: LiAlH4 reduction of spirocyclic indoline 
LiAlH4 (4 eq, 2.00 mmol) was added to a stirred solution of amide (1 eq, 0.50 mmol) in dry THF (15 mL) 
at 0 °C under Ar. The resulting suspension was heated to reflux and stirred for 2.5 h, then the reaction 
was allowed to cool to rt. The reaction was diluted with EtOAc (5 mL) and H2O was carefully added until 
effervescence ceased. NaSO4 was added and the resulting suspension stirred for 30 min, then the mixture 













(4) Solvent and temperature screen of spirocyclisation reaction 
 
General procedure A was followed, using imine 6a (50 mg, 0.381 mmol) and acid 5a (87 mg, 0.457 
mmol) in the specified solvent (2 mL) for 16 h at a specified temperature. The diastereomeric ratio was 
determined by analysis of the unpurified reaction by 1H NMR spectroscopy. Purification by flash column 
chromatography using EtOAc as eluent provided 8a and 9a to give a combined yield (Table 1). 
 




Entry Solvent Temp d.r. Yield (%) 
1 CHCl3 RT 6:1 95 
2 CH2Cl2 RT 7.5:1 91 
3 Toluene RT 7:1 79 
4 MeCN RT 5.5:1 61 
5 THF RT 9:1 82 
6 2-MeTHF RT 7.8:1 74 
7 TBME RT 1:1.1 42 
8 Et2O RT 1:1.4 40 
9 THF 0 °Ca 10.3:1 44 
10 THF 40 °C 8.5:1 91 
11 THF 60 °C 7:1 82 
 






(5) Synthesis of the acid substrates 
 




The following procedure was adapted from a literature protol.7 A mixture of methyl 4-oxopentanoate (354 
μL, 2.86 mmol) and 4-methoxyphenylhydrazine hydrochloride (500 mg, 2.86 mmol) in 2 M HCl/EtOH 
(20 mL) was stirred at 100 °C for 4 h. After cooling to room temperature the solvent was concentrated 
until a solid precipitate was observed. The precipitate was removed by filtration and the filtrate 
concentrated under reduced pressure. The residue was dissolved in CH2Cl2 (50 mL) and washed with H2O 
(50 mL). The aqueous layer was extracted with CH2Cl2 (4 × 50 mL). The combined organics were dried 
(MgSO4) and concentrated under reduced pressure. Purification by flash column chromatography on 
silica with hexane-acetone (9:1 then 8:2) as eluent gave indole ethyl ester SI-1 (404 mg, 57%) as a brown 
oil. Rf  (8:2 hexane/acetone) 0.10; νmax (thin film)/cm
−1 3397 (NH), 2982, 1724 (C=O), 1627, 1592, 1485, 
1216, 1174, 1031, 799; H (400 MHz, CDCl3) 7.74 (s, 1H), 7.15 (d, J = 8.5 Hz, 1H), 7.00 (d, J = 2.5 Hz, 
1H), 6.77 (dd, J = 8.5, 2.5 Hz, 1H), 4.13 (q, J = 7.0 Hz, 2H), 3.86 (s, 3H), 3.64 (s, 2H), 2.40 (s, 3H), 1.24 
(t, J = 7.0 Hz, 3H); δC (100 MHz, CDCl3) 172.0 (C=O), 154.1 (C), 133.4 (C), 130.1 (C), 129.0 (C), 111.0 
(CH), 110.9 (CH), 104.6 (C), 100.5 (CH), 60.6 (CH2), 55.9 (CH3), 30.6 (CH2), 14.3 (CH3), 11.8 (CH3); 
HRMS (ESI) m/z calcd for C14H17NO3 (M + H)
+ 248.1281, found 248.1274 (+3.0 ppm error). These data 
were consistent with the literature values.8  
 
1 M NaOH (10 mL) was added to a stirred solution of ethyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)acetate 
SI-1 (395 mg, 1.60 mmol) in 1:1 THF/MeOH (40 mL). The resulting solution was stirred at room 
temperature for 16 h. The reaction mixture was concentrated under reduced pressure and the resulting 
solid residue dissolved in water (5 mL). The solution was acidified (~pH 1) using conc. HCl resulting in 
the formation of an oily residue. CH2Cl2 (30 mL) and 1 M HCl (40 mL) were added and the two layers 
were separated. The aqueous layer was extracted with CH2Cl2 (2 × 30 mL) and the combined organics 
were dried (MgSO4) and concentrated under reduced pressure to give the indole acetic acid 5b (331 mg, 




(NH), 3104 (OH), 2903, 1723 (C=O), 1589, 1485, 1309, 1209, 1167, 1016, 804, 647; H (DMSO-d6) 
12.03 (s, 1H), 10.65 (s, 1H), 7.12 (d, J = 8.5 Hz, 1H), 6.88 (d, J = 2.5 Hz, 1H), 6.62 (dd, J = 8.5, 2.5, 1H), 
3.72 (s, 3H) 3.52 (s, 2H), 2.29 (s, 3H); δC (100 MHz, DMSO-d6); 173.3 (C=O), 153.0 (C), 133.7 (C), 
130.1 (C), 128.7 (C), 110.9 (CH), 109.5 (CH), 103.8 (C), 100.1 (CH), 55.3 (OCH3), 29.9 (CH2), 11.4 
(CH3); HRMS (ESI) m/z calcd for C12H13NO3 (M + H)
+ 220.0968, found 220.0967 (+0.6 ppm error). 
These data are consistent with the literature values.9  
 




SI-2 was synthesised following a literature procedure.1 A mixture of methyl 4-oxopentanoate (136 μL, 
1.10 mmol) and 4-fluorophenylhydrazine hydrochloride (163 mg, 1.00 mmol) in MeOH (3 mL) and conc. 
H2SO4 (120 μL) was stirred for 10 min at 120 °C in a microwave synthesiser. After being allowed to cool 
to room temperature, H2O (10 mL) was added and the reaction was extracted with CH2Cl2 (3 × 10 mL). 
The combined organics were dried (MgSO4) and concentrated under reduced pressure. Purification by 
flash column chromatography on silica using CH2Cl2 as eluent gave the substituted indole SI-2 (194 mg, 
87%) as a pale yellow oil, Rf  (CH2Cl2) 0.30; H (400 MHz, DMSO-d6) 10.99 (s, 1H), 7.22 (dd, J = 9.0, 
4.5 Hz, 1H), 7.11 (dd, J = 10.0, 2.5 Hz, 1H), 6.82 (ddd, J = 9.0, 9.0, 2.5 Hz, 1H), 3.66 (s, 2H), 3.58 (s, 
3H), 2.32 (s, 3H); δC (100 MHz, DMSO-d6) 171.9 (C=O), 156.8 (d, J = 230.5 Hz, C), 135.6 (C), 131.6 
(C), 128.6 (d, J = 10.0 Hz, C), 111.2 (d, J = 10.0 Hz, CH), 107.9 (d, J = 25.5 Hz, CH), 103.7 (d, J = 4.5 
Hz, C), 102.4 (d, J = 23.5 Hz, CH), 51.5 (OCH3), 29.8 (CH2), 11.4 (CH3); 
19F NMR (376 MHz, d6-
DMSO) δ −125.50 (ddd, J = 10.0, 10.0, 4.5 Hz); HRMS (ESI) m/z calcd for C12H12FNO2 (M + H)
+ 
222.0925, found 222.0932 (−3.3 ppm error). These data are consistent with the literature values.1 
 
1 M NaOH(aq) (10 mL) was added to a stirred solution of methyl 2-(5-fluoro-2-methyl-1H-indol-3-
yl)acetate SI-2 (448 mg, 2.03 mmol) in 1:1 THF/MeOH (40 mL).  The resulting solution was stirred at 
room temperature for 16 h. The reaction mixture was concentrated under reduced pressure and the 
resulting solid residue dissolved in water (5 mL). Conc. HCl was added dropwise until a solid precipitate 
was observed. The solid was isolated by vacuum filtration, washed with water (5 mL) and hexane (5 mL) 
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and air dried to give the indole acetic acid 5c (369 mg, 87%) as a pale orange solid, mp 164–166 °C 
[lit.10 179–182 °C (from MeCN)]; νmax (thin film)/cm
−1 3411 (NH), 2908 (OH), 2736, 2631, 1715 (C=O), 
1587, 1481, 1241, 920, 840, 605; H (400 MHz, DMSO-d6) 12.11 (s, 1H), 10.94 (s, 1H), 7.22 (dd, J = 9.0, 
4.5 Hz, 1H), 7.12 (dd, J = 10.0, 2.5 Hz, 1H), 6.81 (ddd, J = 9.0, 9.0, 2.5, 1H), 3.54 (s, 2H), 2.31 (s, 3H); 
δC (100 MHz, DMSO-d6) 173.1 (C=O), 156.8 (d, J = 230.5 Hz, C), 135.3 (C), 131.6 (C), 128.7 (d, J = 
10.0 Hz, C), 111.1 (d, J = 10.0 Hz, CH), 107.8 (d, J = 26.0 Hz, CH), 104.4 (d, J = 4.5 Hz, C), 102.5 (d, J 
= 23.0 Hz, CH), 29.8 (CH2), 11.4 (CH3); 
19F NMR (376 MHz, CDCl3) δ −125.70 (ddd, J = 10.0, 10.0, 4.5 
Hz); HRMS (ESI) m/z calcd for C11H10FNO2 (M + H)
+ 208.0768, found 208.0771 (−1.4 ppm error). 
 




The following procedure was adapted from a literature protol.11,12 A mixture of 4-oxopentanoic acid (0.59 
mL, 5.79 mmol) and 3,5-dimethylphenylhydrazine hydrochloride (1.00 g, 5.79 mmol) in 2M 
H2SO4/EtOH (40 mL) was stirred at 100 °C for 20 h. The reaction mixture was allowed to cool to rt and 
the solvent was evaporated under reduced pressure. The resulting residue was diluted with water (20 mL) 
and extracted into EtOAc (50 mL). The two layers were separated and the aqueous extracted with EtOAc 
(2 x 50 mL). The combined organics were washed with sat. NaHCO3 (aq) (10 mL), then dried (MgSO4) and 
the solvent evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica using CH2Cl2 as eluent gave the indole ester SI-3 (1.035 g, 72%) as a pale 
yellow solid, mp 84–86 °C (lit.13 101–102 °C); Rf (CH2Cl2) 0.33; νmax (thin film)/cm
−1 3353 (NH), 2978, 
2909, 1710 (C=O), 1624, 1467, 1442, 1330, 1302, 1233, 1157, 1027, 828; H (400 MHz, CDCl3) 7.75 (s, 
1H), 6.85 (d, J = 1.0 Hz, 1H), 6.67 (s, 1H), 4.14 (q, J = 7.0 Hz, 2H), 3.81 (s, 2H), 2.64 (s, 3H), 2.39 (s, 
3H), 2.33 (s, 3H), 1.25 (t, J = 7.0 Hz, 3H); C (100.6 MHz, CDCl3) 172.7 (C=O), 135.7 (C), 132.0 (C), 
130.7 (C), 129.1 (C), 124.6 (C), 123.1 (CH), 108.3 (CH), 104.7 (C), 60.6 (CH2), 31.7 (CH2), 21.3 (CH3), 
19.8 (CH3), 14.2 (CH3), 11.6 (CH3); HRMS (ESI) m/z calcd for C15H19NO2 (M + H)
+ 246.1489, found 




1 M NaOH(aq) (20 mL) was added to a stirred solution of the dimethyl-indole ester SI-3 (930 mg, 3.79 
mmol) in 1:1 MeOH-THF (80 mL) at rt. The resulting solution was stirred at rt for 20 h and then the 
solvent was evaporated under reduced pressure to give the crude product. The residue was taken up in a 
minimum volume of water (5 mL) and conc. HCl(aq) was added dropwise until a solid precipitate was 
observed. The solid was isolated by vacuum filtration, washed with water (5 mL) and hexane (5 mL) and 
air dried to give the indole acetic acid 5d (651 mg, 79%) as a pale red solid, mp 190–192 °C (lit.13 203.5–
204.5 °C); νmax (thin film)/cm
−1 3398 (NH), 2918, 1706 (C=O), 1622, 1561, 1467, 1436, 1400, 1215, 843; 
H (400 MHz, DMSO-d6) 10.62 (s, 1H), 6.85 (s, 1H), 6.47 (s, 1H), 3.65 (s, 2H), 2.49 (s, 3H), 2.29 (s, 3H), 
2.26 (s, 3H); C (100.6 MHz, CDCl3) 174.1 (C=O), 135.6 (C), 132.2 (C), 128.7 (C), 128.0 (C), 124.6 (C), 
121.9 (CH), 108.4 (CH), 104.2 (C), 31.2 (CH2), 21.2 (CH3), 19.5 (CH3), 11.2 (CH3); HRMS (ESI) m/z 
calcd for C13H15NO2 (M + H)
+ 218.1176, found 218.1175 (+0.4 ppm error). 
 
(5-Bromo-2-methyl-1H-indol-3-yl)acetic acid (5e) 
 
\ 
The following procedure was adapted from a literature protol.14 A mixture of 4-oxopentanoic acid (0.46 
mL, 4.47 mmol) and 4-bromophenylhydrazine hydrochloride (1.00 g, 4.47 mmol) in a solution of EtOH 
(6 mL) and conc. H2SO4 (aq) (0.45 mL) was stirred at reflux for 16 h. The reaction mixture was allowed to 
cool to room temperature, then water (20 mL) and EtOAc (20 mL) was added. The two layers were 
separated and the aqueous layer was extracted with EtOAc (1 × 10 mL). The combined organic phases 
were washed with 10% HCl (10 mL) and then sat. NaHCO3 (10 mL), dried (MgSO4) and concentrated 
under reduced pressure. Purification by flash column chromatography on silica using CH2Cl2 as eluent 
gave the indole ester SI-4 (834 mg, 63%) as an orange solid, mp 59–61 °C [lit.15 65–68 °C]; Rf  (CH2Cl2) 
0.30; νmax (thin film)/cm
−1 3355 (NH), 2981, 2901, 1716 (C=O), 1578, 1469, 1434, 1368, 1304, 1260, 
1162, 1030, 793; H (400 MHz, CDCl3) 7.98 (s, 1H), 7.64 (d, J = 2.0 Hz, 1H), 7.17 (dd, J = 8.5, 2.0 Hz, 
1H), 7.07 (d, J = 8.5 Hz, 1H), 4.15 (q, J = 7.0 Hz, 2H), 3.62 (s, 2H), 2.35 (s, 3H), 1.26 (t, J = 7.0 Hz, 3H);  
δC (100 MHz, CDCl3) 171.8 (C=O), 134.1 (C), 133.7 (C), 130.2 (C), 123.9 (CH), 120.7 (CH), 112.7 (C), 
111.6 (CH), 104.3 (C), 60.8 (CH2), 30.2 (CH2), 14.2 (CH2), 11.7 (CH3); HRMS (ESI) m/z calcd for 
C13H14
79BrNO2 (M + H)





1 M NaOH(aq) (10 mL) was added to a stirred solution of bromo-substituted indole ester SI-4 (622 mg, 
2.10 mmol) in 1:1 THF/MeOH (42 mL).  The resulting solution was stirred at room temperature for 8 h. 
The reaction mixture was concentrated under reduced pressure and the residue dissolved in water (5 mL). 
The solution was made acidic (~pH 1) with conc. HCl resulting in the formation of a gummy precipitate. 
The resulting mixture was extracted into EtOAc (30 mL) and the two layers separated. The aqueous was 
extracted into EtOAc (2 x 20 mL) and the combined organics dried (MgSO4) and the solvent evaporated 
under reduced pressure to give the indole acid 5e (513 mg, 91%) as a brown solid, mp 159–161 °C [lit.,10 
189–191 °C]; H (400 MHz, DMSO-d6) 12.12 (br s, 1H), 11.08 (s, 1H), 7.54 (d, J = 2.0 Hz, 1H), 7.21 (d, 
J = 8.5 Hz, 1H), 7.09 (dd, J = 8.5, 2.0 Hz, 1H), 3.56 (s, 2H), 2.32 (s, 3H); δC (100 MHz, DMSO-d6) 173.0 
(C=O), 135.0 (C), 133.7 (C), 130.2 (C), 122.4 (CH), 120.0 (CH), 112.4 (CH), 111.0 (C), 103.9 (C), 29.7 
(CH2), 11.3 (CH3); HRMS (ESI) m/z calcd for C11H10
79BrNO2 (M + H)
+ 267.9968, found 267.9982 (+0.7 
ppm error). These data are consistent with the literature values.17 
 




The following procedure was adapted from a literature protol.18 A mixture of 4-oxopentanoic acid (0.46 
mL, 4.47 mmol) and 2-bromophenylhydrazine hydrochloride (1.0 g, 4.47 mmol) in a solution of EtOH (6 
mL) and conc. H2SO4 (aq) (0.45 mL) was stirred at reflux for 16 h. The reaction mixture was allowed to 
cool to rt and water (20 mL) was added. The resulting mixture was extracted into EtOAc (20 mL), the two 
layers separated and the aqueous extracted with EtOAc (10 mL). The combined organics were washed 
with 10% HCl(aq) (10 mL) and sat. NaHCO3 (aq) (10 mL), then dried (MgSO4) and the solvent evaporated 
under reduced pressure to give the crude product. Purification by flash column chromatography on silica 
using CH2Cl2 as eluent gave the indole ester SI-5 (550 mg, 42%) as an orange solid, mp 64–66 °C; Rf 
(CH2Cl2) 0.44; νmax (thin film)/cm
−1 3350 (NH), 2980, 2912, 1718 (C=O), 1623, 1583, 1491, 1446, 1368, 
1304, 1296, 1151, 1030, 772; H (400 MHz, CDCl3) 8.05 (s, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.27–7.25 (m, 
1H), 6.98 (dd, J = 8.0, 8.0 Hz, 1H), 4.13 (q, J = 7.0 Hz, 2H), 3.66 (s, 2H), 2.44 (s, 3H), 1.24 (t, J = 7.0 Hz, 
3H); C (100.6 MHz, CDCl3) 171.7 (C=O), 133.7 (C), 133.5 (C), 129.6 (C), 123.5 (CH), 120.7 (CH), 
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117.4 (CH), 106.0 (C), 103.9 (C), 60.8 (CH2), 30.6 (CH2), 14.2 (CH3), 11.8 (CH3); HRMS (ESI) m/z 
calcd for C13H14
79BrNO2 (M + H)
+ 296.0281, found 296.0275 (+1.8 ppm error). These data are consistent 
with the literature values.19 
 
1 M NaOH(aq) (8 mL) was added to a stirred solution of the bromo-substituted indole ester SI-5 (459 mg, 
1.55 mmol) in 1:1 MeOH-THF (30 mL) at rt. The resulting solution was stirred at rt for 8 h and then the 
solvent was evaporated under reduced pressure to give the crude product. The residue was taken up in a 
minimum amount of water (5 mL) and the resulting solution was taken to pH 1 with conc. HCl(aq) 
resulting in an oily mixture. The resulting mixture was extracted into CH2Cl2 (50 mL) and the two layers 
separated. The aqueous was extracted into CH2Cl2 (2 x 50 mL) and the combined organics dried (MgSO4) 
and the solvent evaporated under reduced pressure to give the indole acid 5f (360 mg, 86%) as a brown 
solid, mp 128–131 °C (lit.20 160–161 °C); νmax (thin film)/cm
−1 3380 (NH), 2902, 2634, 1690 (C=O), 
1625, 1590, 1558, 1456, 1401, 1225, 1191, 768; H (400 MHz, DMSO-d6) 12.13 (br s, 1H), 11.02 (s, 1H), 
7.39 (d, J = 8.0 Hz, 1H), 7.21–7.19 (m, 1H), 6.89 (dd, J = 8.0, 8.0 Hz, 1H), 3.57 (s, 2H), 2.35 (s, 3H); C 
(100.6 MHz, DMSO-d6) 173.0 (C=O), 135.0 (C), 133.4 (C), 130.0 (C), 122.6 (CH), 119.8 (CH), 117.1 
(CH), 105.5 (C), 103.3 (C), 29.9 (CH2), 11.24 (CH3); HRMS (ESI) m/z calcd for C11H10
79BrNO2 (M + 
H)+ 267.9968, found 267.9974 (−2.4 ppm error). 
 




The following procedure was adapted from a literature protol.7 A mixture of 5-oxohexanoic acid (0.83 
mL, 6.92 mmol) and phenylhydrazine hydrochloride (1.0 g, 6.92 mmol) in a 2M HCl/EtOH solution (6 
mL) was stirred at 100 °C for 4.5 h. The reaction mixture was allowed to cool to rt and the solvent was 
evaporated under reduced pressure. The resulting mixture was diluted with water (200 mL) and extracted 
into EtOAc (100 mL). The two layers were separated and the aqueous extracted with EtOAc (2 x 100 mL). 
The combined organics were dried (MgSO4) and the solvent evaporated under reduced pressure to give 
the crude product. Purification by flash column chromatography on silica using CH2Cl2 as eluent gave the 
indole ester SI-6 (948 mg, 59%) as an orange oil, Rf (CH2Cl2) 0.30; νmax (thin film)/cm
−1 3398 (NH), 
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2980, 2919, 1712 (C=O), 1622, 1362, 1443, 1371, 1299, 1159, 1049, 859; H (400 MHz, CDCl3) 7.76 (br 
s, 1H), 7.51 (d, J = 7.0 Hz, 1H), 7.27–7.25 (m, 1H), 7.14–7.06 (m, 2H), 4.12 (q, J = 7.0 Hz, 2H), 3.04 (t, J 
= 8.0 Hz, 2H), 2.62 (t, J = 8.0 Hz, 2H), 2.39 (s, 3H), 1.23 (t, J = 7.0 Hz, 3H); C (100.6 MHz, CDCl3) 
173.5 (C=O), 135.1 (C), 131.3 (C), 128.1 (C), 120.8 (CH), 119.0 (CH), 117.7 (CH), 110.2 (CH), 109.9 
(C), 60.3 (CH2), 35.1 (CH2), 19.6 (CH2), 14.1 (CH3), 11.3 (CH3); HRMS (ESI) m/z calcd for C14H17NO2 
(M + H)+ 232.1332, found 232.1334 (−0.7 ppm error). These data are consistent with the literature 
values.21  
 
1 M NaOH(aq) (20 mL) was added to a stirred solution of the dimethyl-indole ester SI-6 (888 mg, 3.84 
mmol) in 1:1 MeOH-THF (80 mL) at rt. The resulting solution was stirred at rt for 8 h and then the 
solvent was evaporated under reduced pressure. The resulting residue was taken up in a minimum amount 
of water (5 mL) and the resulting solution was taken to pH 1 with conc. HCl(aq) resulting in an oily residue. 
Water (40 mL) was added and the resulting mixture was extracted into CH2Cl2 (50 mL) and the two 
layers separated. The aqueous was extracted into CH2Cl2 (2 x 50 mL) and the combined organics dried 
(MgSO4) and the solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica using hexane-EtOAc-AcOH (60:39.5:0.5) as eluent gave the 
indole acid 5i (476 mg, 61%) as a yellow solid, mp 121–123 °C (lit.22 132–134 °C); νmax (thin film)/cm
−1 
3384 (NH), 2929, 2634, 1692 (C=O), 1464, 1406, 1308, 1294, 1211, 920; H (400 MHz, DMSO-d6) 12.02 
(s, 1H), 10.68 (s, 1H), 7.39 (d, J = 7.5 Hz, 1H), 7.22–7.20 (m, 1H), 6.97 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 
6.91 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 2.87 (t, J = 7.5 Hz, 2H), 2.45 (t, J = 7.5, 2H), 2.31 (s, 3H); C (100.6 
MHz, DMSO-d6) 174.2 (C=O), 135.2 (C), 131.7 (C), 127.9 (C), 119.9 (CH), 118.1 (CH), 117.3 (CH), 
110.4 (CH), 108.9 (C), 35.1 (CH2), 19.4 (CH2), 11.2 (CH3); HRMS (ESI) m/z calcd for C12H13NO2 (M + 


















The following procedure was adapted from a literature protol.1 A mixture of methyl 4-oxopentanoate (136 
μL, 1.08 mmol) and 5-hydrazinyl-2-methoxypyridine SI-7 (synthesised following a literature procedure,23 
140 mg, 1.00 mmol) in MeOH (3 mL) and conc. H2SO4(aq) (120 μL)  was placed in a suitable microwave 
vessel. The vessel was sealed and the mixture stirred for 10 min at 120 °C in a microwave synthesiser. 
After being allowed to cool to rt, the mixture was diluted with EtOAc (20 mL) and washed with 10% aq. 
HCl (20 mL). The two layers were separated and the aqueous layer was taken to pH 7 with sat. 
NaHCO3(aq). The aqueous layer was extracted into EtOAc (3 x 20 mL) and the combined organics were 
dried (MgSO4) and the solvent evaporated under reduced pressure to give the indole ester SI-8 (181 mg, 
77%) as a brown oil, νmax (thin film)/cm
−1 3344 (NH), 2949, 1722 (C=O), 1619, 1579, 1475, 1436, 1288, 
1241, 1166, 1100, 1023, 803; H (400 MHz, CDCl3) 8.46 (s, 1H), 7.32 (d, J = 8.5 Hz, 1H), 6.42 (d, J = 
8.5 Hz, 1H), 3.94 (s, 3H), 3.77 (s, 2H), 3.69 (s, 3H), 2.31 (s, 3H); C (100.6 MHz, CDCl3) 173.1 (C=O), 
159.6 (C), 142.4 (C), 135.9 (C), 123.6 (C), 120.8 (CH), 104.6 (C), 103.4 (CH), 53.3 (CH3), 51.9 (CH3), 
28.4 (CH2), 12.2 (CH3); HRMS (ESI) m/z calcd for C12H14N2O3 (M + H)
+ 235.1077, found 235.1083 
(−2.6 ppm error). 
 
1 M NaOH(aq) (4 mL) was added to a stirred solution of the azaindole ester SI-8 (183mg, 0.781 mmol) in 
1:1 MeOH-THF (15 mL) at rt. The resulting solution was stirred at rt for 16 h and then the solvent was 
evaporated under reduced pressure. The resulting residue was taken up in a minimum amount of water (5 
mL) and the resulting solution was taken to pH 7 with 5M HCl(aq). The mixture was extracted into EtOAc 
(3 x 20 mL), the combined organics dried (MgSO4) and the solvent evaporated under reduced pressure to 
give azaindole acid 10 (140 mg, 81%) as a yellow solid, 191–193 °C; νmax (thin film)/cm
−1 3192 (NH), 
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2968, 1697 (C=O), 1623, 1581, 1447, 1405, 1315, 1250, 1107, 1017, 818, 592; H (400 MHz, DMSO-d6) 
12.08 (s, 1H), 10.91 (s, 1H), 7.53 (d, J = 8.5 Hz, 1H), 6.42 (d, J = 8.5 Hz, 1H), 3.83 (s, 3H), 3.58 (s, 2H), 
2.32 (s, 3H); C (100.6 MHz, DMSO-d6) 173.1 (C=O), 158.6 (C), 142.3 (C), 136.3 (C), 123.3 (C), 121.0 
(CH), 104.3 (C), 102.7 (CH), 52.4 (CH3), 28.3 (CH2), 12.0 (CH3); HRMS (ESI) m/z calcd for C11H12N2O3 
(M + H)+ 221.0921, found 221.0922 (−0.6 ppm error). 
 




2,4-Dimethylpyrrole (1.00 g, 10.5 mmol) and ethyl diazoacetate (1.20 g, 1.11 ml, 10.5 mmol) were 
dissolved in CH2Cl2 and the resulting solution cooled to 0 °C. Cu(OTf)2 (190 mg, 0.526 mmol) was added 
in portions and effervescence noted. After complete addition the reaction was stirred at r.t. for 1 h. The 
reaction mixture was concentrated and purification by column chromatography (9:1 hexane:EtOAc) gave 
the ester SI-9 (831 mg, 44%) as an orange oil, Rf  (9:1 hexane:EtOAc) 0.30; νmax (thin film)/cm
−1 3384, 
2981, 2924, 2868, 1720, 1399, 1368, 1300, 1239, 1163, 1114, 1027, 782, 638;   H (400 MHz, CDCl3) 
8.16 (br s, 1H), 5.68 (br s, 1H), 4.17 (q, J = 7.0 Hz, 2H), 3.54 (s, 2H), 2.23 (s, 3H), 2.00 (s, 3H), 1.29 (t,  J 
= 7.0 Hz, 3H); δC (100 MHz, CDCl3) 171.5 (C=O), 126.5 (C), 117.7 (C), 115.9 (C), 107.7 (CH), 60.9 
(CH2), 31.2 (CH2), 14.1 (CH3), 12.9 (CH3), 10.6 (CH3); HRMS (ESI): m/z calcd for C10H15NO2 [M + 
H]+ 182.1176, found 182.1175 (−0.2 ppm error). 
 
2 M NaOH(aq) (20 mL) was added to a stirred solution of the pyrrole ester SI-9 (600 mg, 3.31 mmol) in 
1:10 MeOH-THF (2.5:25 mL) at rt and the resulting solution was stirred at rt for 1 h. H2O (20 mL) was 
added and the reaction was washed with EtOAc (50 mL). The aqueous layer was acidified (pH 1) with 
conc. HCl(aq) and extracted with EtOAc (3 x 20 mL). The combined organics were dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the pyrrole acid 12 as a brown oil; (310 mg), H (400 
MHz, CDCl3) 8.04 (br s, 1H), 5.69 (d, J = 2.5 Hz, 1H), 3.59 (s, 2H), 2.23 (s, 3H), 2.01 (s, 3H). The 










A solution of acetophenone (2.00 g, 1.94 mL, 16.6 mmol) and allylamine (4.75 g, 6.24 mL, 83.2 mmol) in 
CH2Cl2 (50 mL) was cooled to 0 °C. TiCl4 (1 M in CH2Cl2) solution (10.7 mL, 10.7 mmol) was added 
dropwise over 40 min. The reaction mixture was then stirred at room temperature for 2 h and the resultant 
precipitate filtered. The filtrate was washed with sat. NaCl (100 mL), dried (MgSO4), filtered and 
concentrated to give the imine SI-10 (2.57 g, 97%) as an orange liquid, νmax (thin film)/cm
−1 H (400 
MHz, CDCl3) 7.78–7.85 (m, 2H), 7.42–7.35 (m, 3H), 6.19–6.07 (m, 1H), 5.27 (ddt, J = 17.0, 1.5, 1.5 Hz, 
1H), 5.16 (ddt, J = 10.5, 1.5, 1.5 Hz, 1H), 4.22–4.17 (m, 2H), 2.26 (s, 3H); δC (100 MHz, CDCl3) 166.2 
(C=N), 141.1 (C), 136.0 (CH), 129.5 (CH), 128.2 (2 × CH), 126.6 (2 × CH), 115.1 (CH2), 54.6 (CH2), 
15.6 (CH3); HRMS (ESI) m/z calcd for C11H13N [M + H]
+ 160.1121, found 160.1126. These data are 
consistent with the literature values.24  
 
Following a modified procedure of Yoshikai;24 Imine SI-10 (2.50 g, 15.7 mmol) was placed in a round 
bottomed flask with a stirrer bar and the flask flushed with O2. Toluene (18.8 mL) and DMSO (1.88 mL) 
were added followed by Bu4NBr (5.06 g, 15.7 mmol) and Pd(OAc)2 (106 mg, 1.57 mmol). The flask was 
flushed a few times with O2 and then the flask was sealed with a suba seal and a balloon of O2 put in 
place. The reaction was stirred at 35 °C for 14 h. Water (100 mL) was added to the reaction and the 
mixture extracted with Et2O (3 × 100 mL). The combined organic phases were dried (MgSO4), filtered, 
and concentrated to give the crude product. Purification by column chromatography (9:1 hexane:EtOAc) 
gave the pyrrole SI-11 (959 mg, 39%) as a pink solid, H (400 MHz, CDCl3) 8.18 (br s, 1H), 7.48–7.43 
(m, 2H), 7.39–7.33 (m, 2H), 7.23–7.17 (m, 1H), 6.66–6.62 (m, 1H), 6.40–6.36 (m, 1H), 2.17 (m, 3H); 
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HRMS (ESI) m/z calcd for C11H11N [M + H]
+ 158.0964, found 158.0962. These data are consistent with 
the literature values.24  
 
Pyrrole SI-11 (750 mg, 4.77 mmol) and ethyl diazoactetate (544 mg, 502 µL, 4.77 mmol) were dissolved 
in CH2Cl2 (10 ml) and stirred at 0 °C. Cu(OTf)2 (86.3 mg, 0.239 mmol) was added carefully in portions. 
The reaction was stirred at 0 °C for 1 h and then allowed to warm to room temperature being concentrated 
to give the crude product. This was purified by column chromatography (9:1 hexane:EtOAc) to give the 
ester SI-12 (390 mg, 34%) as a pink solid, Rf  (9:1 hexane:ethyl acetate) 0.30; νmax (thin film)/cm
−1 3362, 
2977, 2936, 2865, 1704 (C=O), 1593, 1517, 1471, 1291, 1260, 1168, 1126, 1027, 805, 795, 757, 695; 
H (400 MHz, CDCl3) 8.84 (br s, 1H), 7.48–7.43 (m, 2H), 7.38–7.31 (m, 2H), 7.21–7.15 (m, 1H), 6.31 (d, 
J = 2.5 Hz, 1H), 4.21 (q, J = 7.0 Hz, 2H), 3.65 (s, 2H), 2.08 (s, 3H), 1.31 (t, J = 7.0 Hz, 3H); δC (100 
MHz, CDCl3) 171.3 (C=O), 132.7 (C), 130.7 (C), 128.7 (2 × CH), 125.8 (CH), 123.4 (2 × CH), 120.8 (C), 
117.6 (C), 107.5 (CH), 61.1 (CH2), 31.3 (CH2), 14.1 (CH3), 10.8 (CH3); HRMS (ESI): calcd for 
C15H17NO2 [M + H]
+ 244.1332, found 244.1334 (−0.9 ppm error). 
 
Ester SI-12 (340 mg, 1.397 mmol) was dissolved in THF (1.79 mL) and MeOH (199 µL) and 2M KOH 
(2.98 mL) was added. The reaction was stirred for 16 h at rt, water (10 mL) was added and the reaction 
washed with EtOAc (10 mL). The aqueous layer was acidified (pH 1) with conc. HCl(aq) and extracted 
with EtOAc (3 x 10 mL). The combined organics were dried (MgSO4) and the solvent evaporated under 
reduced pressure to give the crude product. Flash column chromatography on silica using EtOAc as 
eluent gave the pyrrole acid 13 (194 mg, 64%) as a yellow oil, Rf  (EtOAc) 0.35; νmax (thin film)/cm
−1 
3424, 2912, 2866, 1696, 1518, 1390, 1264, 1221, 918, 809, 761, 694, 523;  H (400 MHz, CDCl3) 8.63 
(br s, 1H), 7.48–7.41 (m, 2H), 7.38–7.31 (m, 2H), 7.22–7.15 (m, 1H), 6.32 (d, J = 3.0 Hz, 1H), 3.70 (s, 
2H), 2.08 (s, 3H); δC (100 MHz, CDCl3) 176.9 (C=O), 132.6 (C), 131.1 (C), 128.8 (2 × CH), 126.0 (CH), 
123.5 (2 × CH), 119.9 (C), 118.3 (C), 107.7 (CH), 31.3 (CH2), 10.8 (CH3); HRMS (ESI): calcd for 
C13H13NO2 [M + Na]















Following a modified procedure of Lightner and Holmes;25 Diketo ester SI-1326 (4.43 g, 23.788 mmol) 
was dissolved in acetic acid (12.6 mL) and the solution stirred at 80 °C. At this temperature NaOAc (6.24 
g, 76.122 mmol, 3.2 eq.) and zinc dust (5.29 g, 80.880 mmol, 3.4 eq.) were added as solids. The reaction 
temperature was increased to 95 °C and at this temperature a solution of diethyl oximinomalonate SI-1427 
(4.50 g, 23.788 mmol, 1 eq.) in AcOH / H2O (5.71 mL / 2.38 mL) was added dropwise over 30 min. The 
reaction mixture was then heated at 100 °C for 1 h before being allowed to cool. Ice was added and the 
reaction mixture shaken and then stored in a fridge overnight. The resultant solids were filtered and 
washed with H2O. Purification by column chromatography (9:1 to 4:1 hexane:EtOAc) gave the pyrrole 
SI-15 (1.67 g, 28%) as a white solid, mp 82–82 °C [lit.,25 93–95 °C (from EtOH)]; Rf  (4:1 
hexane:EtOAc) 0.25; νmax (thin film)/cm
−1 3294, 2984, 2956, 2903, 1729, 1663 (C=O), 1444, 1264, 
1252, 1218, 1170, 1093, 1022, 918, 774, 751;   H (400 MHz, CDCl3) 8.73 (br s, 1H), 4.30 (q, J = 7.0 Hz, 
2H), 4.13 (q, J = 7.0 Hz, 2H), 3.37 (s, 2H), 2.29 (s, 3H), 2.24 (s, 3H), 1.35 (t, J = 7.0 Hz, 3H), 1.25 (t, J = 
7.0 Hz, 3H); δC (100 MHz, CDCl3) 171.8 (C=O), 161.7 (C=O), 130.8 (C), 127.5 (C), 117.1 (C), 114.5 
(C), 60.6 (CH2), 59.7 (CH2), 30.2 (CH2), 14.5 (CH3), 14.2 (CH3), 11.5 (CH3), 10.6 (CH3); HRMS 
(ESI): calcd for C13H19NO4 [M + Na]
+ 276.1206, found 276.1201. These data are consistent with the 
literature values.25 
 
The pyrrole diester SI-15 was dissolved in water (3.2 mL) and EtOH (1.6 mL) and heated to 70 °C. The 
reaction was stirred for 30 min then allowed to cool to rt. 10 % HCl(aq) (10 mL) and the reaction was 
extracted with EtOAc (3 x 10 mL). The combined organics were dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the acid 16 (192 mg, 54%) as a brown solid, mp 160–162 °C 
(lit.25 194–196 °C) Rf  (EtOAc) 0.55; νmax (thin film)/cm
−1 3304, 2985, 2917, 1706, 1670 (C=O), 1444, 
1274, 1218, 1172, 1091, 770, 722, 699, 623;  H (400 MHz, DMSO-d6) 12.07 (br s, 1H), 11.15 (br s, 1H), 
4.19 (q, J = 7.0 Hz, 2H), 3.24 (s, 2H), 2.15 (s, 3H), 2.11 (s, 3H), 1.26 (t, J = 7.0 Hz, 3H); δC (100 MHz, 
DMSO-d6) 173.0 (C=O), 160.9 (C=O), 131.5 (C), 126.5 (C), 116.0 (C), 114.6 (C), 58.8 (CH2), 29.7 
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(CH2), 14.6 (CH3), 10.9 (CH3), 10.5 (CH3); HRMS (ESI): calcd for C11H15NO4 [M + Na]
+ 248.0893, 












































N-Bromosuccinimide (840 mg, 4.72 mmol) was added portionwise to a stirred solution of 6,7-dimethoxy-
1,2,3,4-tetrahydroisoquinoline 6b (830 mg, 4.30 mmol) in CH2Cl2 (20 mL) at 0 °C under Ar. The 
resulting solution was stirred at 0 °C for 1 h. NaOH(aq) (30% w/v, 9 mL) was added and the reaction was 
stirred at rt for 2 h. The two layers were separated and the organic layer was washed with water (50 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica using EtOAc-MeOH (98:2) as eluent gave the imine 6b (766 mg, 93%) 
as a pale yellow oil, Rf  (95:5 EtOAc-MeOH) 0.15; H (400 MHz, CDCl3) 8.23 (s, 1H), 6.81 (s, 1H), 6.67 
(s, 1H), 3.91 (s, 3H), 3.90 (s, 3H), 3.75–3.70 (m, 2H), 2.70–2.66 (m, 2H); C (100.6 MHz, CDCl3) 159.6 
(C=N), 151.1 (C), 147.8 (C), 129.8 (C), 121.5 (C), 110.3 (CH), 110.3 (CH), 56.1 (CH3), 56.0 (CH3), 47.3 







3-Thiophene acetic acid (3.80 g, 26.7 mmol) was dissolved in CH2Cl2 (45 mL) and stirred at room 
temperature. Oxalyl chloride (2.49 mL, 29.4 mmol, 1.1 eq.) was added and the reaction stirred at room 
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temperature overnight. Aqueous ammonium hydroxide (16 mL) was added slowly, in portions. Water 
(100 mL), sat. NaHCO3 (100 mL), and EtOAc (200 mL) were added. The organic phase was isolated and 
the aqueous phase was extracted with EtOAc (2 × 100 mL). The combined organics were dried (MgSO4), 
filtered, and concentrated to give the amide SI-16 (3.19 g, 85%) as a white solid, Rf  (EtOAc) 0.30; νmax 
(thin film)/cm−1 3344, 3159, 1631 (C=O), 1409, 1282, 1243, 831, 783, 734, 648, 596, 585;   H (400 
MHz, CDCl3) 7.36 (dd, J = 5.0, 3.0 Hz, 1H), 7.19–7.16 (m, 1H), 7.03 (dd, J = 5.0, 1.5 Hz, 1H), 5.72 (br s, 
1H), 5.50 (br s, 1H), 3.63 (s, 2H); HRMS (ESI) m/z calcd for C6H7NOS [M + H]
+ 142.0321, found 
142.0319 (+1.3 ppm error). These data are consistent with the literature values.29 
 
A suspension of amide SI-16 (2.00 g, 14.2mmol) in THF (12 mL) was cooled to 0 °C. BH3∙THF (1 M) 
(70.8 mL, 70.8 mmol, 5 eq.) was added in portions. The reaction was stirred at 35 °C overnight before 
being allowed to cool to room temperature. MeOH (50 mL) was added (note: effervescence) followed by 
6 M HCl (50 mL) and the reaction mixture stirred for 2 h. The reaction was then diluted with H2O (50 mL) 
and the resulting solution washed with EtOAc (50 mL). The aqueous phase was isolated, made basic with 
2 M NaOH, and extracted with EtOAc (4 × 50 mL). The combined organic phases were dried (MgSO4), 
filtered, and concentrated to give the crude product, which contained amine SI-17, as a colourless oil 
(1.10 g), H (400 MHz, CDCl3) 7.29 (dd, J = 5.0, 3.0 Hz, 1H), 7.03–6.99 (m, 1H), 6.97 (dd, J = 5.0, 1.5 
Hz, 1H), 2.98 (m, 2H), 2.80 (t, J = 7.0 Hz, 2H); HRMS (ESI) m/z calcd for C6H9NS [M + H]
+ 128.0528, 
found 128.0534. These data are consistent with the literature values.30 
 
The crude material, containing amine SI-17, was dissolved in ethyl formate (25 mL) and stirred at reflux 
for 5 h. The reaction mixture was concentrated, dissolved in CH2Cl2 (50 mL) and washed with 10% HCl 
(50 mL) and then sat. NaHCO3 (50 mL). The organic phase was dried (MgSO4), filtered, and 
concentrated to give the crude product, which contained formate SI18, as a brown oil (616 mg), H (400 
MHz, CDCl3) 8.15 (s, 1H), 7.31 (dd, J = 5.0, 3.0 Hz, 1H), 7.05–7.02 (m, 1H), 6.97 (dd, J = 5.0, 1.5 Hz, 
1H), 5.64 (br s, 1H), 3.58 (m, 2H), 2.89 (t, J = 7.0 Hz, 2H).  
The crude material, containing formate SI-18, was dissolved in MeCN (8.57 mL). POCl3 (429 µL) was 
added and the reaction mixture stirred at room temperature for 4 h. The reaction mixture was concentrated, 
dissolved in EtOAc (50 mL), and washed with sat. NaHCO3 (50 mL). The organic phase was dried 
(MgSO4), filtered, and concentrated to give the imine 6d (351 mg, 18% over 3 steps) as a brown oil, H 
(400 MHz, CDCl3) 8.29 (s, 1H), 7.38 (d, J = 5.0 Hz, 1H), 6.93 (d, J = 5.0 Hz, 1H), 3.81 (td, J = 8.5, 2.0 
Hz, 2H), 2.77 (t, J = 8.5 Hz, 2H); δC (100 MHz, CDCl3) 152.5 (CH), 140.7 (C), 129.5 (C), 127.7 (CH), 
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126.6 (CH), 47.6 (CH2), 22.7 (CH2); HRMS (ESI): calcd for C7H7NS [M + H]
+ 138.0372, found 






N-Methyl-2-pyrrole carboxaldehyde (10.0 g, 91.634 mmol), NH4OAc (3.91 g, 47.650 mmol), and MeNO2 
(50 mL) were stirred at reflux for 2 h. The mixture was allowed to cool and the MeNO2 removed under 
vacuum. The residue was dissolved in CH2Cl2 (100 mL), washed with water (2 × 100 mL), dried 
(MgSO4), filtered, and concentrated to give the crude product (14.9 g), which contained nitrostyrene SI-
19, H (400 MHz, CDCl3) 8.00 (d, J = 13.0 Hz, 1H), 7.47 (d, J = 13.0 Hz, 1H), 6.97–6.93 (m, 1H), 6.81 
(dd, J = 4.0, 1.5 Hz, 1H), 6.28 (dd, J = 4.0, 2.5 Hz, 1H), 3.78 (s, 3H); HRMS (ESI): calcd for C7H8N2O2 
[M + Na]+ 175.0478, found 175.0483. These data are consistent with the literature values.32 
 
Following a modified procedure of Glennon;33 the crude material from above, containing nitroalkene SI-
19 (14.9 g, 97.930 mmol) was dissolved in THF (400 mL) and LiAlH4 (11.15 g, 293.789 mmol, 3.0 eq.) 
was added in portions very carefully. The resulting mixture was stirred at room temperature for 5 h. TLC 
at this stage showed the starting material to be consumed. The reaction mixture was cooled to 0 °C and 
quenched very carefully with H2O before being filtered through a pad of celite. The celite was washed 
with EtOAc (2 × 200 mL). The filtrate was treated with 10% aq. HCl (200 mL) and the aqueous phase 
isolated. This was basified with 2 M NaOH and extracted with EtOAc (3 × 200 mL). The combined 
organic phases were dried (MgSO4), filtered, and concentrated to give the crude product, which contained 
amine SI-20, as a brown oil, H (400 MHz, CDCl3) 6.57 (dd, J = 2.5, 2.0 Hz, 1H), 6.09–6.06 (m, 1H), 
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5.95–5.92 (m, 1H), 3.56 (s, 3H), 2.97 (t, J = 7.0 Hz, 2H), 2.72 (t, J = 7.0 Hz, 2H); HRMS (ESI): calcd for 
C7H12N2 [M + H]
+ 125.1073, found 125.1068. These data are consistent with the literature values.34 
The crude material, containing amine SI-20, was dissolved in ethyl formate (10 mL) and stirred at reflux 
for 5 h. The reaction mixture was concentrated, dissolved in CH2Cl2 (25 mL) and washed with 10% HCl 
(25 mL) and then sat. NaHCO3 (25 mL). The organic phase was dried (MgSO4), filtered, and 
concentrated to give the crude product (8.21 g), as a brown oil. Purification by column chromatography 
(EtOAc) gave the formate SI-21 (2.33 g, 17% over 3 steps), H (400 MHz, CDCl3) 8.16 (s, 1H), 6.59 (m, 
1H), 6.08 (t, J = 3.0 Hz, 1H), 5.95 (m, 1H), 5.76 (br s, 1H), 3.60–3.53 (m, 2H), 3.57 (s, 3H), 2.82 (t, J = 
7.0 Hz, 2H); HRMS (ESI) m/z calcd for C8H12N2O [M + Na]
+ 175.0842, found 175.0839. These data are 
consistent with the literature values.33 
 
Following a modified procedure of Glennon;33 formate SI-21 (500 mg, 3.285 mmol) was dissolved in 
toluene (15.0 mL). The reaction was heated to reflux and POCl3 (500 µL) added dropwise. The reaction 
was stirred at reflux for 1 h. The mixture was allowed to cool and washed with hot water (3 × 25 mL). 
The combined aqueous layers were washed with CH2Cl2 (3 × 15 mL) and basified by the addition of 
KOH. This alkaline aqueous phase was extracted with CH2Cl2 (3 × 25 mL), dried (MgSO4), filtered, and 
concentrated to give imine 6e (115 mg, 26%) as a yellow film, H (400 MHz, CDCl3) 8.21 (t, J = 2.0 Hz, 
1H), 6.50 (d, J = 3.0 Hz, 1H), 6.18 (d, J = 3.0 Hz, 1H), 3.85–3.78 (m, 2H), 3.55 (s, 3H), 2.70–2.63 (m, 
2H); HRMS (ESI): calcd for C8H10N [M + H]
+ 135.0917, found 135.0918. These data are consistent with 

















(7) Acid scope in the DIA spirocyclisation reaction 
 
(1'R*,10b'R*)-2-Methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-
one (8a) and (1'R*,10b'S*)-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-
3'(10b'H)-one (9a) 
   
 
     8a    9a 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5a (172 mg, 0.909 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 11:1 mixture of 8a:9a based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9a (18 mg, 8%), a 1:3.3 mixture of 9a:8a (27 mg, 12%) and 8a (166 mg, 72%). 
Total combined yield of 8a and 9a: 211 mg, 92%. 8a was recrystallised from EtOAc and an X-ray 
crystal structure obtained. CCDC 1436464 contains the supplementary crystallographic data for this 
paper The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif 
 
9a: Yellow oil, Rf  (EtOAc) 0.25; νmax (thin film)/cm
−1 3070, 2920, 2855, 1690 (C=O), 1578, 1458, 1424, 
1305, 925, 758, 731; δH (400 MHz, CDCl3) 7.58 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.46 (ddd, 
J = 7.5, 7.5, 1.0 Hz, 1H), 7.36 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.12–7.09 (m, 2H), 6.91–6.85 (m, 1H), 5.93 
(d, J = 7.5 Hz, 1H), 5.36 (s, 1H), 4.58–4.53 (m, 1H), 3.16–3.02 (m, 3H), 2.89–2.85 (m, 1H), 2.58 (d, J = 
17.0 Hz, 1H), 1.85 (s, 3H); δC (100.6 MHz, CDCl3) 182.4 (C=N), 170.0 (C=O), 154.8 (C), 140.2 (C), 
133.0 (C), 132.0 (C), 129.3 (CH), 129.1 (CH), 127.7 (CH), 127.3 (CH), 126.3 (CH), 123.7 (CH), 121.6 
(CH), 120.6 (CH), 61.7 (C), 61.6 (CH), 40.1 (CH2), 37.1 (CH2), 28.5 (CH2), 17.2 (CH3); HRMS (ESI) m/z 
calcd for C20H18N2O (M + H)
+ 303.1492, found 303.1497 (−1.8 ppm error). 
 
8a: Yellow solid, mp 177–179 °C; Rf (EtOAc) 0.15; νmax (thin film)/cm
−1  3070, 2921, 1690 (C=O), 1577, 
1458, 1429, 1414, 1305, 909, 726; δH (400 MHz, CDCl3) 7.40 (d, J = 7.5 Hz, 1H), 7.11 (ddd, J = 7.5, 7.5, 
1.0 Hz, 1H), 6.99–6.91 (m, 3H), 6.86 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.78 (dd, J = 7.5, 7.5 Hz, 1H), 6.32 
(d, J = 7.5 Hz, 1H), 5.27 (s, 1H), 4.58–4.53 (m, 1H), 3.10 (d, J = 16.0 Hz, 1H), 3.09–2.97 (m, 2H), 2.82–
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2.77 (m, 1H), 2.60 (s, 3H), 2.44 (d, J = 16.0 Hz, 1H); 13C NMR (100.6 MHz, CDCl3) 180.4 (C=N), 170.4 
(C=O), 153.7 (C), 140.3 (C), 133.3 (C), 132.0 (C), 129.0 (CH), 128.4 (CH), 127.1 (CH), 126.6 (CH), 
125.5 (CH), 123.5 (CH), 120.9 (CH), 120.1 (CH), 63.3 (C), 60.4 (CH), 39.9 (CH2), 37.3 (CH2), 28.9 
(CH2), 16.4 (CH3); HRMS (ESI) m/z calcd for C20H18N2O (M + H)




3'(10b'H)-one (8b) and (1'R*,10b'S*)-5-methoxy-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9b) 
 
    
 
         8b           9b 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5b (199 mg, 0.907 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 6:1 mixture of 8b:9b based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9b (38 mg, 15%), a 1:3 mixture of 9b:8b (18 mg, 7%) and 8b (160 mg, 63%). 
Total combined yield of 8b and 9b: 216 mg, 85%. 
 
9b: Pale orange solid, mp 168-171°C; Rf (EtOAc) 0.25; νmax (thin film)/cm
−1 2923, 2836, 1690 (C=O), 
1596, 1576, 1473, 1431, 1305, 1026, 909, 727; δH (400 MHz, CDCl3) 7.48 (d, J = 8.5 Hz, 1H), 7.12–7.10 
(m, 2H), 7.08 (d, J = 2.5 Hz, 1H), 6.95 (dd, J = 8.5, 2.5 Hz, 1H), 6.92–6.88 (m, 1H), 5.99 (d, J = 8.0 Hz, 
1H), 5.30 (s, 1H), 4.56–4.52 (m, 1H), 3.88 (s, 3H), 3.15–3.02 (m, 3H), 2.92-2.84 (m, 1H), 2.59 (d, J = 
17.0 Hz, 1H), 1.81 (s, 3H); δC (100.6 MHz, CDCl3) 180.2 (C=N), 170.0 (C=O), 158.7 (C), 148.3 (C), 
141.8 (C), 133.0 (C), 132.1 (C), 129.2 (CH), 127.7 (CH), 127.3 (CH), 123.8 (CH), 121.0 (CH), 113.4 
(CH), 108.4 (CH), 61.9 (C), 61.7 (CH), 55.8 (CH3), 40.5 (CH2), 37.1 (CH2), 28.5 (CH2), 17.1 (CH3); 
HRMS (ESI) m/z calcd for C21H20N2O2 (M + H)
+ 333.1598, found 333.1594 (+0.3 ppm error) 
 
8b: Pale orange solid, mp 121–124 °C; Rf (EtOAc) 0.15; νmax (thin film)/cm
−1  2934, 2836, 1689, 1610, 
1579, 1470, 1431, 1305, 1178, 907, 724; δH (400 MHz, CDCl3) 7.28 (d, J = 8.5 Hz, 1H), 6.99–6.92 (m, 
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2H), 6.82–6.78 (m, 1H), 6.62 (dd, J = 8.5, 2.5 Hz, 1H), 6.52 (d, J = 2.5 Hz, 1H), 6.33 (d, J = 8.0 Hz, 1H), 
5.25 (s, 1H), 4.56–4.51 (m, 1H), 3.57 (s, 3H), 3.11–2.95 (m, 3H), 2.83–2.78 (m, 1H), 2.55 (s, 3H), 2.43 (d, 
J = 16.5 Hz, 1H); δC (100.6 MHz, CDCl3) 178.0 (C=N), 170.4 (C=O), 157.8 (C), 147.5 (C), 141.8 (C), 
133.2 (C), 132.0 (C), 129.0 (CH), 127.1 (CH), 126.7 (CH), 123.6 (CH), 120.3 (CH), 113.2 (CH), 107.5 
(CH), 63.3 (C), 60.7 (CH), 55.5 (CH3), 40.0 (CH2), 37.3 (CH2), 29.0 (CH2), 16.2 (CH3); HRMS (ESI) m/z 
calcd for C21H20N2O2 (M + H)
+ 333.1598, found 333.1595 (+0.8 ppm error).  
 
(1'R*,10b'R*)-5-Fluoro-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-
3'(10b'H)-one (8c) and (1'R*,10b'S*)-5-fluoro-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9c)  
 
    
 
         8c           9c 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5c (188 mg, 0.907 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 6:1 mixture of 8c:9c based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9c (21 mg, 9%) and 8c (177 mg, 72%). Total combined yield of 8c and 9c: 198 
mg, 81%. 
 
9c: Yellow oil, Rf  (EtOAc) 0.25; νmax (thin film)/cm
−1  2925, 1696 (C=O), 1601, 1466, 1421, 1306, 1156, 
732; δH (400 MHz, CDCl3) 7.53 (dd, J = 8.5, 4.5 Hz, 1H), 7.25 (dd, J = 7.5, 2.5 Hz, 1H), 7.17–7.12 (m, 
3H), 6.93–6.89 (m, 1H), 5.96 (d, J = 8.0 Hz, 1H), 5.32 (s, 1H), 4.58–4.53 (m, 1H), 3.16–3.02 (m, 3H), 
2.90–2.85 (m, 1H), 2.60 (d, J = 17.0 Hz, 1H), 1.84 (s, 3H); δC NMR (100.6 MHz, CDCl3) 182.3 (C=N), 
169.7 (C=O), 161.6 (d, J = 245.5 Hz, CF), 150.7 (d, J = 2.0 Hz, C), 142.2 (d, J = 8.5 Hz, C), 133.1 (C), 
131.8 (C), 129.4 (CH), 127.9 (CH), 127.4 (CH), 123.6 (CH), 121.5 (d, J = 8.5 Hz, CH), 115.8 (d, J = 23.5 
Hz, CH), 109.5 (d, J = 25.0 Hz, CH), 62.1 (d, J = 2.0 Hz, C), 61.6 (CH), 40.1 (CH2), 37.2 (CH2), 28.5 
(CH2), 17.2 (CH3); 
19F NMR (376 MHz, CDCl3) δ −115.00 (ddd, J = 8.5, 8.5, 4.5 Hz); HRMS (ESI) m/z 
calcd for C20H17FN2O (M + H)




8c: Yellow solid, mp 193–196 °C; Rf (EtOAc) 0.15; νmax (thin film)/cm
−1  2924, 1694 (C=O), 1598, 1462, 
1415, 1178, 920, 727; δH (400 MHz, CDCl3) 7.33 (dd, J = 8.5, 4.5 Hz, 1H), 7.02–6.95 (m, 2H), 6.83–6.78 
(m, 2H), 6.68 (dd, J = 8.0, 2.5 Hz, 1H), 6.32 (d, J = 8.0 Hz, 1H), 5.26 (s, 1H), 4.56–4.52 (m, 1H), 3.12–
2.96 (m, 3H), 2.84–2.79 (m, 1H), 2.58 (s, 3H), 2.43 (d, J = 16.5 Hz, 1H); δC (100.6 MHz, CDCl3) 180.3 
(C=N), 170.1 (C=O), 160.8 (d, J = 245.5 Hz, CF), 149.8 (d, J = 2.0 Hz, C), 142.1 (d, J = 9.0 Hz, C), 
133.3 (C), 131.6 (C), 129.3 (CH), 127.3 (CH), 126.8 (CH), 123.4 (CH), 120.8 (d, J = 9.0 Hz, CH), 115.1 
(d, J = 23.5 Hz, CH), 108.9 (d, J = 25.5 Hz, CH), 63.8 (d, J = 2.0 Hz, C), 60.3 (CH), 39.8 (CH2), 37.3 
(CH2), 28.9 (CH2), 16.4 (CH3); 
19F NMR (376 MHz, CDCl3) δ −115.90 (ddd, J = 8.5, 8.5, 4.5 Hz); 
HRMS (ESI) m/z calcd for C20H17FN2O (M + H)
+ 321.1398, found 321.1384 (+4.3 ppm error).  
 
(1'R*,10b'R*)-2,4,6-Trimethyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-
3'(10b'H)-one (8d) and (1'R*,10b'S*)-2,4,6-trimethyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9d) 
 
   
  
          8d     9d 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5d (197 mg, 0.907 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 9:1 mixture of 8d:9d based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished a mixture of 9d with minor contaminants (24 mg, 10%) and 8d (198 mg, 78%).  
 
8d: Pale orange solid, mp 128–130 °C; Rf (EtOAc) 0.10; νmax (thin film)/cm
−1 3055, 2923, 1688 (C=O), 
1626, 1593, 1459, 1433, 1305, 1264, 851, 729; δH NMR (400 MHz, CDCl3) 7.16 (s, 1H), 7.02–6.97 (m, 
2H), 6.75–6.71 (m, 1H), 6.50 (s, 1H), 6.04 (d, J = 8.0 Hz, 1H), 5.21 (s, 1H), 4.59–4.54 (m, 1H), 3.23–3.08 
(m, 2H), 2.99 (d, J = 17.5 Hz, 1H), 2.83–2.78 (m, 1H), 2.65 (d, J = 17.5 Hz, 1H), 2.52 (s, 3H), 2.24 (s, 
3H), 1.83 (s, 3H); δC (100.6 MHz, CDCl3) 182.5 (C=N), 170.6 (C=O), 154.9 (C), 138.3 (C), 136.1 (C), 
133.2 (C), 132.8 (C), 132.7 (C), 128.9 (CH), 128.8 (CH), 127.1 (CH), 126.2 (CH), 125.0 (CH), 118.7 
(CH), 61.3 (C), 59.7 (CH), 37.9 (2 x CH2), 27.6 (CH2), 21.1 (CH3), 19.2 (CH3), 16.0 (CH3); HRMS (ESI) 
m/z calcd for C22H22N2O (M + H)





3'(10b'H)-one (8e) and (1'R*,10b'S*)-5-bromo-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9e) 
 
    
 
        8e           9e 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5e (243 mg, 0.906 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 12:1 mixture of 8e:9e based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9e (28 mg, 9%) and 8e (250 mg, 87%). Total combined yield of 8e and 9e: 278 
mg, 96%. 9e was recrystallised from EtOAc and an X-ray crystal structure obtained.  
 
9e: Orange oil; Rf (EtOAc) 0.25; νmax (thin film)/cm
−1 2926, 2867, 1696 (C=O), 1604, 1578, 1455, 1423, 
1305, 1186, 735; δH (400 MHz, CDCl3) 7.67 (d, J = 2.0 Hz, 1H), 7.58 (dd, J = 8.0, 2.0 Hz, 1H), 7.45 (d, J 
= 8.0 Hz, 1H), 7.14–7.11 (m, 2H), 6.93–6.89 (m, 1H), 5.96 (d, J = 8.0 Hz, 1H), 5.34 (s, 1H), 4.57–4.52 
(m, 1H), 3.15–3.02 (m, 3H), 2.89–2.85 (m, 1H), 2.58 (d, J = 17.0 Hz, 1H), 1.83 (s, 3H); δC NMR (100.6 
MHz, CDCl3) 183.0 (C=N), 169.6 (C=O), 153.8 (C), 142.4 (C), 133.1 (C), 132.7 (CH), 131.7 (C), 129.4 
(CH), 127.9 (CH), 127.4 (CH), 125.1 (CH), 123.6 (CH), 122.0 (CH), 119.8 (C), 62.0 (C), 61.4 (CH), 40.0 
(CH2), 37.1 (CH2), 28.4 (CH2), 17.2 (CH3); HRMS (ESI) m/z calcd for C20H17BrN2O (M + H)
+ 381.0597 
found 381.0598 (−0.1 ppm error). 
 
8e: Orange solid, mp 164–167 °C; Rf (EtOAc) 0.15; νmax (thin film)/cm
−1 2918, 2852, 1695 (C=O), 1648, 
1604, 1572, 1449, 1423, 1410, 1302, 1246, 1193, 803, 760, 739; δH (400 MHz, CDCl3) 7.28–7.24 (m, 
2H), 7.13–7.12 (m, 1H), 7.05–6.98 (m, 2H), 6.83 (dd, J = 7.5, 7.5 Hz, 1H), 6.33 (d, J = 8.0 Hz, 1H), 5.27 
(s, 1H), 4.59–4.54 (m, 1H), 3.13–2.97 (m, 3H), 2.86–2.81 (m, 1H), 2.60 (s, 3H), 2.45 (d, J = 16.5 Hz, 1H); 
δC (100.6 MHz, CDCl3) 180.8 (C=N), 170.0 (C=O), 152.7 (C), 142.3 (C), 133.3 (C), 131.5 (CH), 131.4 
(C), 129.3 (CH), 127.5 (CH), 126.8 (CH), 124.3 (CH), 123.3 (CH), 121.4 (CH), 119.2 (C), 63.9 (C), 60.4 
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(CH), 39.7 (CH2), 37.3 (CH2), 28.9 (CH2), 16.5 (CH3); HRMS (ESI) m/z calcd for C20H17BrN2O (M + 
H)+ 381.0597, found 381.0597 (−0.1 ppm error).  
 
(1'R*,10b'R*)-7-Bromo-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-
3'(10b'H)-one (8f) and (1'R*,10b'S*)-7-bromo-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9f) 
 
    
 
    8f        9f 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5f (243 mg, 0.906 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 13:1 mixture of 8f:9f based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9f (24 mg, 8%), a 1:2.3 mixture of 9f:8f (11 mg, 4%) and 8f (227 mg, 78%). 
Total combined yield of 8f and 9f: 262 mg, 90%.  
 
9f: Orange oil, Rf  (4:1 EtOAc-hexane) 0.25; νmax (thin film)/cm
−1 2933, 2861, 1690 (C=O), 1575, 1458, 
1421, 1306, 1181, 783, 736; δH (400 MHz, CDCl3) 7.61 (d, J = 8.0 Hz, 1H), 7.47 (d, J = 7.5 Hz, 1H), 
7.26–7.22 (m, 1H), 7.15–7.10 (m, 2H), 6.94–6.90 (m, 1H), 5.95 (d, J = 8.0 Hz, 1H), 5.35 (s, 1H), 4.57-
4.52 (m, 1H), 3.15–3.01 (m, 3H), 2.89–2.84 (m, 1H), 2.58 (d, J = 17.0 Hz, 1H), 1.89 (s, 3H); δC (100.6 
MHz, CDCl3) 184.0 (C=N), 169.6 (C=O), 153.1 (C), 142.0 (C), 133.0 (C), 132.6 (CH), 131.7 (C), 129.4 
(CH), 127.9 (CH), 127.7 (CH), 127.6 (CH), 123.5 (CH), 120.6 (CH), 114.5 (C), 63.4 (C), 61.5 (CH), 40.2 
(CH2), 37.2 (CH2), 28.5 (CH2), 17.5 (CH3); HRMS (ESI) m/z calcd for C20H17
79BrN2O (M + Na)
+ 
403.0416 found 403.0400 (+4.1 ppm error). 
 
8f: Orange solid, mp 190–192 °C; Rf (4:1 EtOAc-hexane) 0.15; νmax (thin film)/cm
−1 2940, 2858, 1692, 
1571, 1456, 1431, 1417, 1302, 1195, 803, 760; δH (400 MHz, CDCl3) 7.26 (d, J = 8.0 Hz, 1H), 6.99–6.93 
(m, 2H), 6.90 (d, J = 7.5 Hz, 1H), 6.82 (dd, J = 7.5, 7.5 Hz, 1H), 6.73 (dd, J = 7.5, 7.5 Hz, 1H), 6.32 (d, J 
= 8.0 Hz, 1H), 5.28 (s, 1H), 4.55–4.51 (m, 1H), 3.11–2.95 (m, 3H), 2.82–2.78 (m, 1H), 2.65 (s, 3H), 2.41 
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(d, J = 16.5 Hz, 1H); δC (100.6 MHz, CDCl3) 182.1 (C=N), 169.9 (C=O), 151.9 (C), 142.0 (C), 133.2 (C), 
131.8 (CH), 131.6 (C), 129.1 (CH), 127.3 (CH), 126.9 (CH), 126.8 (CH), 123.4 (CH), 119.9 (CH), 113.9 
(C), 64.9 (C), 60.3 (CH), 39.9 (CH2), 37.3 (CH2), 28.8 (CH2), 16.7 (CH3); HRMS (ESI) m/z calcd for 
C20H17
79BrN2O (M + H)
+ 381.0597, found 381.0597 (0.0 ppm error). 
 
(1'R*,10b'R*)-5',6'-Dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (8g) and 
(1'R*,10b'S*)-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9g) 
 
    
 
    8g           9g 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5g (159 mg, 0.908 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 11:1 mixture of 8g:9g based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished a mixture of 9g and a minor contaminant (18 mg, 8%) and 8g (160 mg, 73%). 
Total combined yield of 8g and 9g: 178 mg, 81%. 
 
9g: Pale yellow solid, mp 155–158 °C; Rf (EtOAc) 0.20; νmax (thin film)/cm
−1 3026, 2925, 1687 (C=O), 
1608, 1458, 1431, 1415, 1306, 923, 768, 730; δH (400 MHz, CDCl3) 8.42 (s, 1H), 7.52 (d, J = 8.0 Hz, 1H), 
7.18 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H), 7.01–6.92 (m, 4H), 6.81–6.77 (m, 1H), 6.44 (d, J = 8.0 Hz, 1H), 5.50 
(s, 1H), 4.58–4.54 (m, 1H), 3.32 (dd, J = 16.5, 1.5 Hz, 1H), 3.14–2.99 (m, 2H), 2.84–2.79 (m, 1H), 2.43 
(d, J = 16.5 Hz, 1H); δC NMR (100.6 MHz, CDCl3) 173.2 (C=N), 170.0 (C=O), 154.6 (C), 139.3 (C), 
133.5 (C), 131.8 (C), 129.1 (CH), 128.6 (CH), 127.2 (CH), 126.7 (CH), 126.6 (CH), 123.7 (CH), 121.4 
(CH), 121.2 (CH), 63.3 (C), 58.7 (CH), 37.9 (CH2), 37.4 (CH2), 29.1 (CH2);  HRMS (ESI) m/z calcd for 
C19H16N2O (M + H)











   
 
 8h    9h 
 
General procedure A was followed using imine 6a (53 mg, 0.404 mmol), acid 5h (125 mg, 0.497 mmol), 
DIPEA (132 μL, 0.758 mmol) and T3P (394 mg of a 50% w/v solution in THF, 0.619 mmol), in THF (2 
mL) for 16 h at RT. The unpurified reaction mixture contained 8:1 mixture of 9h:8h based on analysis 
by 1H NMR spectroscopy. Purification by flash column chromatography with EtOAc-hexane (1:1) as 
eluent sequentially furnished a 1:1.1 mixture of 8h:9h (57 mg, 38%) and 9h (49 mg, 33%). Total 
combined yield of 8h and 9h: 106 mg, 71%. 9h was recrystallised from EtOAc and an X-ray crystal 
structure was obtained. CCDC 1436405 contains the supplementary crystallographic data for this paper. 
The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
Diagnostic signals for 8h: δH (400 MHz, CDCl3) 6.23 (d, J = 8.0 Hz, 1H), 5.77 (s, 1H), 4.68-4.64 (m, 1H).  
 
9h: Cream solid, mp 201–203 °C; Rf (EtOAc) 0.20; νmax (thin film)/cm
−1 3062, 2931, 1689 (C=O), 1522, 
1494, 1458, 1420, 1307, 910, 754, 694; δH (400 MHz, CDCl3) 7.74 (d, J = 7.5 Hz, 1H), 7.59 (d, J = 7.0 
Hz, 1H), 7.51 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.45–7.41 (m, 1H), 7.31–7.27 (m, 1H), 7.16 (dd, J = 8.0, 8.0 
Hz, 2H), 7.09–7.06 (m, 2H), 6.99 (dd, J = 7.5, 7.5 Hz, 1H), 6.87 (dd, J = 7.5, 7.5 Hz, 1H), 6.71 (d, J = 7.5 
Hz, 1H), 5.98 (d, J = 8.0 Hz, 1H), 5.40 (s, 1H), 4.36–4.31 (m, 1H), 3.30 (dd, J = 17.5, 1.0 Hz, 1H), 3.21 
(d, J = 17.5 Hz, 1H), 2.91 (ddd, J = 13.0, 13.0 Hz, 3.0 Hz, 1H), 2.36 (dd, J = 16.0, 3.0 Hz, 1H), 1.80 (ddd, 
J = 16.5, 13.0, 6.0 Hz, 1H); δC (100.6 MHz, CDCl3) 181.0 (C=N), 170.7 (C=O), 154.4 (C), 141.5 (C), 
134.7 (C), 134.1 (C), 131.6 (C), 130.1 (CH), 129.3 (CH), 128.5 (CH), 127.9 (CH), 127.5 (CH), 127.4 
(CH), 127.0 (CH), 126.7 (CH), 123.6 (CH), 121.6 (CH), 121.4 (CH), 62.8 (C), 62.7 (CH), 40.9 (CH2), 
37.0 (CH2), 27.6 (CH2); HRMS (ESI) m/z calcd for C25H20N2O (M + H)
+ 365.1648, found 365.1646 (+0.6 






one (8i) and (1'R*,11b'S*)-2-methyl-2',3',6',7'-tetrahydrospiro[indole-3,1'-pyrido[2,1-
a]isoquinolin]-4'(11b'H)-one (9i) 
 
     
 
        8i          9i 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 5i (184 mg, 0.905 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 4:1 mixture of 8i:9i based on analysis by 1H 
NMR spectroscopy. Purification by flash column chromatography with EtOAc-MeOH (98:2) as 
eluent sequentially furnished a 4.8:1 mixture of 8i:9i (96 mg, 40%) and 8i (77 mg, 32%). Total 
combined yield of 8i and 9i: 173 mg, 72%. 
 
8i: Yellow solid, mp 156–158 °C; Rf (98:2 EtOAc-MeOH) 0.20; νmax (thin film)/cm
−1 2928, 2867, 1640 
(C=O), 1577, 1455, 1432, 1410, 1247, 1047, 731; δH (400 MHz, CDCl3) 7.35 (d, J = 7.5 Hz, 1H), 7.14 
(ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.09 (d, J = 7.5 Hz, 1H), 6.94 (dd, J = 8.0, 8.0 Hz, 1H), 6.90–6.86 (m, 2H), 
6.82–6.78 (m, 1H), 6.54 (d, J = 8.0 Hz, 1H), 5.32 (s, 1H), 5.06–5.01 (m, 1H), 2.94–2.74 (m, 4H), 2.64–
2.60 (m, 1H), 2.62 (s, 3H), 2.44 (ddd, J = 13.5, 9.5, 8.0 Hz, 1H), 1.46 (dd, J = 13.5, 5.0, 5.0 Hz, 1H); δC 
NMR (100.6 MHz, CDCl3) 183.0 (C=N), 169.3 (C=O), 154.2 (C), 139.1 (C), 135.7 (C), 132.4 (C), 128.7 
(CH), 128.3 (CH), 126.9 (CH), 126.0 (CH), 125.0 (CH), 123.6 (CH), 123.0 (CH), 120.3 (CH), 61.8 (C), 
60.4 (CH), 39.7 (CH2), 29.2 (2 x CH2), 28.0 (CH2), 17.1 (CH3); HRMS (ESI) m/z calcd for C21H20N2O 
(M + H)+ 317.1648 found 317.1646 (+1.1 ppm error).  
 
Diagnostic peaks for 9i: δH (400 MHz, CDCl3) 5.81 (d, J = 8.0 Hz, 1H), 5.40 (s, 1H), 1.97 (s, 3H); HRMS 
(ESI) m/z calcd for C21H20N2O (M + H)















(8) Imine scope in the DIA spirocyclisation reaction 
 
(1'R*,10b'R*)-8',9'-Dimethoxy-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-
a]isoquinolin]-3'(10b'H)-one (8j) and (1'R*,10b'S*)-8',9'-dimethoxy-2-methyl-5',6'-dihydro-2'H-
spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9j) 
 
   
 
        8j         9j 
 
General procedure A was followed using imine 6b (145 mg, 0.762 mmol), acid 5a (172 mg, 0.909 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 3:1 mixture of 8j:9j based on analysis by 1H 
NMR spectroscopy. Purification by flash column chromatography with EtOAc-MeOH (98:2) as 
eluent sequentially furnished 9j (44 mg, 16%), a 1:3 mixture of 9j:8j and 8j (143 mg, 52%). Total 
combined yield of 8j and 9j: 202 mg, 72%. 
 
9j: Yellow oil, Rf (EtOAc) 0.25; νmax (thin film)/cm
−1 2932, 2853, 1692 (C=O), 1518, 1457, 1433, 1256, 
1027, 800; δH (400 MHz, CDCl3) 7.58–7.53 (m, 2H), 7.43 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H), 7.37 (ddd, J = 
7.5, 7.5, 1.0 Hz, 1H), 6.54 (s, 1H), 5.34 (s, 1H), 5.27 (s, 1H), 4.56–4.51 (m, 1H), 3.80 (s, 3H), 3.24 (s, 
3H), 3.13–2.91 (m, 3H), 2.79–2.74 (m, 1H), 2.59 (d, J = 17.0 Hz, 1H), 1.90 (s, 3H); δC (100.6 MHz, 
CDCl3) 182.9 (C=N), 170.1 (C=O), 155.0 (C), 148.3 (C), 147.3 (C), 140.0 (C), 129.2 (CH), 126.3 (CH), 
124.9 (C), 123.5 (C), 121.8 (CH), 120.4 (CH), 111.3 (CH), 105.7 (CH), 61.9 (C), 61.8 (CH), 55.8 (CH3), 
55.0 (CH3), 39.7 (CH2), 37.1 (CH2), 27.9 (CH2), 17.4 (CH3); HRMS (ESI) m/z calcd for C22H22N2O3 (M + 
H)+ 363.1703, found 363.1688 (+4.3 ppm error). 
 
8j: Yellow solid, mp 163–165 °C; Rf (EtOAc) 0.15; νmax (thin film)/cm
−1 2933, 2835, 1693 (C=O), 1518, 
1457, 1256, 1124, 770, 730; δH (400 MHz, CDCl3) 7.42 (d, J = 7.5 Hz, 1H), 7.17–7.13 (m, 1H), 6.94–
6.87 (m, 2H), 6.43 (s, 1H), 5.72 (s, 1H), 5.21 (s, 1H), 4.53 (dd, J = 13.5, 5.0 Hz, 1H), 3.73 (s, 3H), 3.48 (s, 
3H), 3.12–3.08 (m, 2H), 2.95 (ddd, J = 13.5, 13.5, 5.0 Hz, 1H), 2.74–2.69 (m, 1H), 2.62 (s, 3H), 2.47 (d, J 
= 16.5 Hz, 1H); δC (100.6 MHz, CDCl3) 181.0 (C=N), 170.4 (C=O), 153.8 (C), 147.7 (C), 147.6 (C), 















(CH), 63.1 (C), 60.2 (CH), 55.6 (CH3 x 2), 39.8 (CH2), 37.5 (CH2), 28.3 (CH2), 16.4 (CH3); HRMS (ESI) 
m/z calcd for C22H22N2O3 (M + H)
+ 363.1703, found 363.1694 (+2.5 ppm error).  
 
(1'R*,10b'S*)-7',10'-Dibromo-8',9'-dimethoxy-2-methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (8k) and (1'R*,10b'R*)-7',10'-dibromo-8',9'-dimethoxy-2-
methyl-5',6'-dihydro-2'H-spiro[indole-3,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (9k) 
 
   
 
8k     9k 
 
General procedure A was followed using imine 6c (210 mg, 0.602 mmol), acid 5a (136 mg, 0.719 mmol), 
DIPEA (193 μL, 1.11 mmol) and T3P (572 mg of a 50% w/v solution in THF, 0.899 mmol), in THF (3.2 
mL) for 1 h at 70 °C. The unpurified reaction mixture contained 9:1 mixture of 8k:9k based on 
analysis by 1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as 
eluent sequentially furnished 9k (27 mg, 8%) and 8k (222 mg, 71%). Total combined yield of 8k and 
9k: 249 mg, 79%. 
 
9k: Yellow solid, mp 149–151 °C; Rf (EtOAc) 0.35; νmax (thin film)/cm
−1 2927, 2854, 1698 (C=O), 1576, 
1459, 1408, 1293, 1025, 979, 772; δH (400 MHz, CDCl3) 7.53-7.51 (m, 1H), 7.46 (d, J = 7.5 Hz, 1H), 
7.35 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.29 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 5.63 (s, 1H), 4.65–4.57 (m, 1H), 
3.87 (s, 3H), 3.71 (s, 3H), 3.05–2.97 (m, 2H), 2.92–2.84 (m, 2H), 2.59 (d, J = 18.0 Hz, 1H), 1.66 (s, 3H); 
δC (100.6 MHz, CDCl3) 180.5 (C=N), 170.7 (C=O), 154.3 (C), 150.4 (C), 150.1 (C), 144.4 (C), 134.0 (C), 
131.3 (C), 128.6 (CH), 126.2 (CH), 121.5 (CH), 120.4 (CH), 120.2 (C), 117.1 (C), 63.4 (CH), 61.8 (C), 
60.9 (CH3), 60.7 (CH3), 40.8 (CH2), 37.4 (CH2), 31.0 (CH2), 16.7 (CH3); HRMS (ESI) m/z calcd for 
C22H20
79Br2N2O3 (M + H)
+ 518.9913, found 518.9928 (−2.7 ppm error). 
 
8k: Yellow solid, mp 156–158 °C; Rf (EtOAc) 0.10; νmax (thin film)/cm
−1 2936, 1693 (C=O), 1579, 1526, 
1456, 1401, 1295, 1114, 1023, 756; δH (400 MHz, CDCl3) 7.38 (d, J = 7.5 Hz, 1H), 7.11 (ddd, J = 7.5, 
7.5, 1.0 Hz, 1H), 6.77 (dd, J = 7.5, 7.5 Hz, 1H), 6.36 (d, J = 7.5, 7.5 Hz, 1H), 5.47 (s, 1H), 4.61–4.51 (m, 
1H), 3.73 (s, 3H), 3.41 (s, 3H), 3.01–2.84 (m, 4H), 2.60 (s, 3H), 2.36 (d, J = 17.5 Hz, 1H); δC (100.6 MHz, 
S33 
 
CDCl3) 183.2 (C=N), 170.9 (C=O), 154.4 (C), 149.9 (C), 149.5 (C), 140.3 (C), 133.6 (C), 131.1 (C), 
128.1 (CH), 124.9 (CH), 121.3 (CH), 120.2 (CH), 119.9 (C), 117.8 (C), 61.9 (C), 61.8 (CH), 60.7 (CH3), 
60.6 (CH3), 40.0 (CH2), 37.7 (CH2), 30.9 (CH2), 16.5 (CH3); HRMS (ESI) m/z calcd for C22H20
79Br2N2O3 
(M + H)+ 518.9913, found 518.9937 (−4.6 ppm error). 
 
(3R*,9a'S*)-2-Methyl-8',9a'-dihydro-4'H-spiro[indole-3,9'-thieno[3,2-g]indolizin]-7'(5'H)-one 8l 
and (3S*,9a'S*)-2-methyl-8',9a'-dihydro-4'H-spiro[indole-3,9'-thieno[3,2-g]indolizin]-7'(5'H)-one 9l 
 
    
 
       8l        9l 
 
General procedure A was followed using imine 6d (105 mg, 0.762 mmol), acid 5a (172 mg, 0.909 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 9:1 mixture of 8l:9l based on analysis by 1H 
NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent furnished an 
unknown mixture of diastereoisomers 8l and 9l (190 mg, 81%). Repeated chromatography furnished a 
small amount of separated diastereoisomers for characterisation purposes only.  
 
8l: Yellow solid, mp 178–181 °C (from 2:3 hexane/EtOAc); Rf  (EtOAc) 0.20; νmax (thin film)/cm
−1 
3081, 2969, 2933, 2900, 2839, 1695, 1684 (C=O), 1574, 1424, 1406, 1313, 1248, 887, 879, 759, 745; 
H (400 MHz, CDCl3) 7.48 (d, J = 7.5 Hz, 1H), 7.21 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.02 (d, J = 7.5 Hz, 
1H), 6.94 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.90 (d, J = 5.0 Hz, 1H), 6.62 (d, J = 5.0 Hz, 1H), 5.33 (s, 1H), 
4.65–4.57 (m, 1H), 3.14–3.03 (m, 1H), 3.13 (dd, J = 16.0, 1.5 Hz, 1H), 2.86–2.79 (m, 2H), 2.54 (s, 3H), 
2.49 (d, J = 16.0 Hz, 1H); δC (100 MHz, CDCl3) 179.1 (C=N), 170.5 (C=O), 154.1 (C), 139.5 (C), 
134.4 (C), 130.0 (C), 128.6 (CH), 126.4 (CH), 125.5 (CH), 124.3 (CH), 121.2 (CH), 120.1 (CH), 63.1 
(C), 59.9 (CH), 39.6 (CH2), 37.3 (CH2), 25.4 (CH2), 16.3 (CH3); HRMS (ESI) m/z calcd for 
C18H16N2OS (M + H)
+ 309.1056, found 309.1047 (+2.8 ppm error). 
 
9l: Yellow oil, Rf  (EtOAc) 0.25; νmax (thin film)/cm
−1;  H (400 MHz, CDCl3) 7.63–7.58 (m, 1H), 7.51–
7.44 (m, 2H), 7.39–7.32 (m, 1H), 7.03 (d, J = 5.0 Hz, 1H), 6.77 (d, J = 5.0 Hz, 1H), 5.36 (s, 1H), 4.65–











1H), 1.97 (s, 3H); δC (100 MHz, CDCl3) 181.8 (C=N), 170.3 (C=O), 155.2 (C), 137.7 (C), 134.4 (C), 
129.5 (CH), 129.1 (C), 126.6 (CH), 126.2 (CH), 124.9 (CH), 121.6 (CH), 120.6 (CH), 61.6 (CH), 
39.5 (CH2), 37.1 (CH2), 25.2 (CH2), 17.5 (CH3); HRMS (ESI): m/z calcd for C18H16N2OS (M + H)
+ 
309.1056, found 309.1042 (+4.4 ppm error). 
 
(3R*,9a'R*)-2,3'-Dimethyl-4',5',8',9a'-tetrahydrospiro[indole-3,9'-pyrrolo[2,3-g]indolizin]-7'(3'H)-
one (8m) and (3R*,9a'S*)-2,3'-dimethyl-4',5',8',9a'-tetrahydrospiro[indole-3,9'-pyrrolo[2,3-
g]indolizin]-7'(3'H)-one (9m) 
 
    
 
    8m     9m 
 
General procedure A was followed using imine 6e (105 mg, 0.762 mmol), acid 5a (172 mg, 0.909 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained 5:1 mixture of 8m:9m based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc then EtOAc-MeOH 
(95:5) as eluent furnished a 3.5:1 mixture of 8m and 9m (190 mg, 81%) as a yellow solid. 
Recrystallization from EtOAc enabled isolation of the major diastereoisomer as a yellow solid.  
 
8m: Yellow solid, mp 168–170 °C (EtOAc) Rf  (ethyl acetate) 0.15; νmax (thin film)/cm
−1 3385, 2916, 
2847, 1688 (C=O), 1577, 1422, 1299, 1218, 751, 709; H (400 MHz, CDCl3) 7.57 (d, J = 8.0 Hz, 1H), 
7.47 (d, J = 7.0 Hz, 1H), 7.45–7.38 (m, 1H), 7.31 (dd, J = 7.0, 7.0 Hz, 1H), 6.34 (d, J = 3.0 Hz, 1H), 5.21 
(s, 1H), 4.95 (d, J = 3.0 Hz, 1H), 4.68–4.60 (m, 1H), 3.47 (s, 3H), 3.15–3.04 (m, 1H), 3.08 (d, J = 17.0 Hz, 
1H), 2.84–2.66 (m, 2H), 2.57 (d, J = 17.0 Hz, 1H), 1.89 (s, 3H); δC (100 MHz, CDCl3) 183.2 (C=N), 
170.7 (C=O), 154.9 (C), 139.4 (C), 128.8 (CH), 125.8 (CH), 124.8 (C), 122.1 (CH), 121.6 (CH), 
120.2 (CH), 113.2 (C), 102.3 (CH), 61.2 (C), 60.7 (CH), 39.6 (CH2), 36.8 (CH2), 33.0 (CH3), 21.2 
(CH2), 17.7 (CH3); HRMS (ESI): m/z calcd for C19H19N3O (M + H)
+ 306.1601, found 306.1612 (−3.5 
ppm error). 
 
Diagnostic signals for 9m: H (400 MHz, CDCl3) 7.46 (d, J = 8.0 Hz, 1H), 7.23–7.16 (m, 1H), 6.97–6.89 













3.15–3.04 (m, 1H), 3.08 (d, J = 16.0 Hz, 1H), 2.84–2.66 (m, 2H), 2.52 (s, 3H), 2.47 (d, J = 16.0 Hz, 1H); 
δC (100 MHz, CDCl3) 180.4 (C=N), 171.0 (C=O), 153.9 (C), 140.6 (C), 127.9 (CH), 125.1 (C), 125.0 
(CH), 122.0 (CH), 121.6 (CH), 119.7 (CH), 113.2 (C), 101.8 (CH), 62.7 (C), 59.1 (CH), 39.7 (CH2), 37.1 
(CH2), 32.9 (CH3), 21.3 (CH2), 16.3 (CH3). 
 
(1'R*,8a'R*)-8',8'-Dibenzyl-2-methyl-6',7',8',8a'-tetrahydro-2'H-spiro[indole-3,1'-indolizin]-
3'(5'H)-one (8n) and (1'R*,8a'S*)-8',8'-dibenzyl-2-methyl-6',7',8',8a'-tetrahydro-2'H-spiro[indole-
3,1'-indolizin]-3'(5'H)-one (9n) 
 
    
 
8n     9n 
 
General procedure A was followed using imine 6f (60 mg, 0.228 mmol), acid 5a (53 mg, 0.280 mmol), 
DIPEA (74 μL, 0.425 mmol) and T3P (219 mg of a 50% w/v solution in THF, 0.344 mmol), in toluene (1 
mL) for 18 h at 90 °C. The unpurified reaction mixture contained 3:1 mixture of 8n:9n based on 
analysis by 1H NMR spectroscopy. Purification by flash column chromatography with EtOAc-Et2O 
(10:90 then 20:80 then 50:50) as eluent sequentially furnished 9n (26 mg, 26%) and 8n (63 mg, 63%). 
Total combined yield of 8n and 9n: 89 mg, 89%. 8n was recrystallised from EtOAc to obtain an X-ray 
crystal structure. CCDC 1436396 contains the supplementary crystallographic data for this paper The data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
9n: Yellow oil, Rf  (EtOAc) 0.50; νmax (thin film)/cm
−1 3029, 2932, 1686 (C=O), 1601, 1556, 1454, 1441, 
1265, 732, 701; δH (400 MHz, CDCl3) 7.69 (d, J = 7.5 Hz, 1H), 7.43 (dd, J = 7.5, 7.5 Hz, 1H), 7.35–7.20 
(m, 7H), 7.02–6.98 (m, 1H), 6.90 (dd, J = 7.5, 7.5 Hz, 2H), 6.40 (d, J = 7.5 Hz, 2H), 4.39 (dd, J = 13.0, 
5.0 Hz, 1H), 3.77 (s, 1H), 3.30 (d, J = 13.5 Hz, 1H), 3.00 (d, J = 13.5 Hz, 1H), 2.93–2.88 (m, 4H), 2.64 
(ddd, J = 13.0, 13.0, 3.5 Hz, 1H), 2.49 (d, J = 14.0 Hz, 1H), 2.46 (d, J = 14.0 Hz, 1H), 2.39 (d, J = 16.5 
Hz, 1H), 2.19–2.04 (m, 1H), 1.59–1.52 (m, 2H), 1.09–1.01 (m, 1H); δC (100.6 MHz, CDCl3) 180.1 (C=N), 
171.3 (C=O), 152.4 (C), 145.3 (C), 136.8 (C), 135.8 (C), 131.0 (CH), 130.8 (CH), 128.9 (CH), 128.3 
(CH), 127.6 (CH), 126.82 (CH), 126.79 (CH), 126.2 (CH), 120.7 (CH), 120.4 (CH), 71.4 (CH), 61.2 (C), 
S36 
 
42.5 (C), 40.9 (CH2), 40.8 (CH2), 39.7 (CH2), 35.7 (CH2), 31.0 (CH2), 21.9 (CH3), 20.0 (CH2); HRMS 
(ESI) m/z calcd for C30H30N2O (M + H)
+ 435.2431, found 435.2445 (−3.3 ppm error). 
 
8n: Brown solid, mp 225–227 °C; Rf (EtOAc) 0.35; νmax (thin film)/cm
−1 3028, 2938, 1683 (C=O), 1589, 
1454, 1422, 1283, 908, 728; δH (400 MHz, CDCl3) 8.07 (d, J = 7.5 Hz, 1H), 7.71 (d, J = 7.5 Hz, 1H), 7.48 
(dd, J = 7.5, 7.5 Hz, 1H), 7.40 (dd, J = 7.5, 7.5 Hz, 1H), 7.36–7.28 (m, 3H), 7.24-7.22 (m, 2H), 7.09–7.07 
(m, 3H), 6.33–6.31 (m, 2H), 4.41 (dd, J = 13.0, 5.5 Hz, 1H), 3.47 (d, J = 13.5 Hz, 1H), 3.35–3.32 (m, 2H), 
3.13 (d, J = 17.5 Hz, 1H), 2.54 (ddd, J = 13.0, 13.0, 3.5 Hz, 1H), 2.45 (d, J = 13.5 Hz, 1H), 2.33 (d, J = 
17.5 Hz, 1H), 2.19 (s, 3H), 2.20–2.10 (m, 1H), 2.09 (d, J = 13.5 Hz, 1H), 1.56–1.50 (m, 2H), 1.24–1.17 
(m, 1H); δC (100.6 MHz, CDCl3) 185.1 (C=N), 170.6 (C=O), 156.1 (C), 137.6 (C), 136.6 (C), 135.9 (C), 
130.84 (CH), 130.75 (CH), 129.5 (CH), 128.3 (CH), 127.8 (CH), 126.7 (CH), 126.7 (CH), 126.2 (CH), 
125.9 (CH), 125.4 (CH), 121.2 (CH), 64.8 (CH), 60.0 (C), 43.3 (C), 40.4 (CH2), 40.0 (CH2), 38.7 (CH2), 
34.8 (CH2), 31.1 (CH2), 20.2 (CH2), 16.0 (CH3); HRMS (ESI) m/z calcd for C30H30N2O (M + H)
+ 
435.2431, found 435.2447 (−3.8 ppm error).  
 
(2'R*,3R*)-2'-(4-Methoxyphenyl)-1',2-dimethylspiro[indole-3,3'-pyrrolidin]-5'-one (8o) and 
(2'S*,3R*)-2'-(4-methoxyphenyl)-1',2-dimethylspiro[indole-3,3'-pyrrolidin]-5'-one (9o)  
 
   
 
8o     9o 
 
General procedure A was followed using imine 6g (113 mg, 0.757 mmol), acid 5a (172 mg, 0.909 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 1 h at 70 °C. The unpurified reaction mixture contained 4:1 mixture of 8o:9o based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent 
sequentially furnished 9o (32 mg, 13%) and 8o (141 mg, 58%). Total combined yield of 8o and 9o: 
173 mg, 71%. 8o was recrystallised from EtOAc to obtain an X-ray crystal structure. CCDC 1436400 
contains the supplementary crystallographic data for this paper The data can be obtained free of charge 




9o: Orange oil, Rf  (EtOAc) 0.40; νmax (thin film)/cm
−1  2926, 1694 (C=O), 1612, 1573, 1513, 1459, 1396, 
1250, 1176, 1031, 732; δH (400 MHz, CDCl3) 7.51 (d, J = 7.5 Hz, 1H), 7.42–7.36 (m, 2H), 7.29–7.25 (m, 
1H), 6.89–6.84 (m, 4H), 4.66 (s, 1H), 3.80 (s, 3H), 2.99–2.95 (m, 4H), 2.52 (d, J = 16.5 Hz, 1H), 1.62 (s, 
3H); δC (100.6 MHz, CDCl3) 181.4 (C=N), 173.3 (C=O), 160.0 (C), 143.8 (C), 128.8 (CH), 128.2 (C), 
127.4 (CH), 127.1 (C), 126.3 (CH), 120.4 (CH), 120.2 (CH), 114.5 (CH), 70.4 (CH), 61.8 (C), 55.3 (CH3), 
36.8 (CH2), 29.2 (CH3), 17.7 (CH3); HRMS (ESI) m/z calcd for C20H20N2O2 (M + H)
+ 321.1598, found 
321.1594 (+1.0 ppm error).  
 
8o: Orange solid, mp 166–168 °C; Rf (EtOAc) 0.20; νmax (thin film)/cm
−1 2910, 1682 (C=O), 1608, 1583, 
1511, 1455, 1248, 1171, 1023, 843, 774; δH (400 MHz, CDCl3) 7.42 (d, J = 7.5 Hz, 1H), 7.18 (ddd, J = 
7.5, 7.5, 1.0 Hz, 1H), 6.82–6.74 (m, 5H), 6.03 (d, J = 7.5 Hz, 1H), 4.40 (s, 1H), 3.78 (s, 3H), 2.97–2.92 
(m, 4H), 2.44 (d, J = 17.0 Hz, 1H), 2.38 (s, 3H); δC (100.6 MHz, CDCl3) 183.3 (C=N), 173.1 (C=O), 
159.7 (C), 154.4 (C), 137.1 (C), 128.4 (CH), 128.1 (CH), 127.7 (C), 125.1 (CH), 123.8 (CH), 119.7 (CH), 
114.0 (CH), 67.0 (CH), 61.0 (C), 55.3 (CH3), 36.8 (CH2), 29.0 (CH3), 16.1 (CH3); HRMS (ESI) m/z calcd 
for C20H20N2O2 (M + H)
+ 321.1598, found 321.1589 (+2.6 ppm error).  
 
(2'R*,3R*)-2'-(4-Methoxyphenyl)-1'-methyl-2-phenylspiro[indole-3,3'-pyrrolidin]-5'-one (8p) and 
(2'S*,3R*)-2'-(4-methoxyphenyl)-1'-methyl-2-phenylspiro[indole-3,3'-pyrrolidin]-5'-one (9p) 
 
   
 
8p     9p 
 
General procedure A was followed using imine 6g (45 mg, 0.302 mmol), acid 5h (90 mg, 0.358 mmol), 
DIPEA (116 μL, 0.666 mmol) and T3P (286 mg of a 50% w/v solution in THF, 0.449 mmol), in THF (1.5 
mL) for 1 h at 70 °C. The unpurified reaction mixture contained 1.8:1 mixture of 8p:9p based on 
analysis by 1H NMR spectroscopy. Purification by flash column chromatography with hexane-EtOAc 
(1:1) as eluent furnished an inseparable 1:1.2 mixture of diastereoisomers. Total yield of 8p and 9p: 
73 mg, 76%. 
 
8p and 9p: Pale brown solid, mp 169–171 °C; Rf  (1:1 hexane-EtOAc) 0.20; νmax (thin film)/cm
−1 3060, 
2932, 1693 (C=O), 1612, 1586, 1513, 1458, 1304, 1249, 1176, 1032, 911, 731; δH (400 MHz, CDCl3) for 
S38 
 
a 1.2:1 mixture of diastereoisomers 7.99–7.97 (m, 2.4H), 7.61 (m, 1H), 7.56–7.48 (m, 7.8H), 7.46–7.42 
(m, 1.2H), 7.39–7.34 (m, 2H), 7.27 (dd, J = 7.5, 7.5 Hz, 2H), 7.20–7.16 (m, 1.2H), 6.95–6.91 (m, 1.2H), 
6.71–6.64 (m, 5.8H), 6.44–6.40 (m, 2H), 6.35–6.32 (m, 2H), 3.70 (s, 3.6H), 3.64 (s, 3H), 3.44 (d, J = 18.0 
Hz, 1H), 3.23 (d, J = 18.0 Hz, 1.2H), 3.06 (d, J = 18.0 Hz, 1H), 3.05 (d, J = 18.0 Hz, 1.2H), 2.92 (s, 3H), 
2.84 (s, 3.6H); δH (100.6 MHz, CDCl3) 179.6 (C=N), 179.0 (C=N), 174.4 (C=O), 173.8 (C=O), 159.4 (C), 
159.3 (C), 153.6 (C), 153.4 (C), 140.6 (C), 134.6 (C), 132.4 (C), 131.1 (CH), 130.3 (CH), 129.0 (CH), 
128.96 (CH), 128.3 (CH), 128.2 (CH), 128.1 (CH), 127.89 (CH), 127.88 (CH), 127.4 (CH), 127.3 (C), 
126.9 (CH), 125.7 (CH), 125.4 (C), 123.5 (CH), 121.1 (CH), 120.8 (CH), 120.7 (CH), 113.6 (CH), 113.3 
(CH), 71.8 (CH), 68.4 (CH), 61.7 (C), 61.1 (C), 55.2 (CH3), 55.1 (CH3), 39.4 (CH2), 39.3 (CH2), 29.7 
(CH3), 29.5 (CH3); HRMS (ESI) m/z calcd for C25H22N2O2 (M + H)










General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 10 (200 mg, 0.908 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in THF (4 mL) 
for 16 h at RT. The unpurified reaction mixture contained a >20:1 mixture of 11 based on analysis by 
1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as eluent furnished 
11 (226 mg, 89%). 
 
11: Yellow solid, mp 139–141 °C; Rf  (EtOAc) 0.10; νmax (thin film)/cm
−1 2939, 1687 (C=O), 1594, 1472, 
1407, 1307, 1222, 1145, 1022, 909, 829, 645; δH (400 MHz, CDCl3) 7.50 (d, J = 8.0 Hz, 1H), 6.96–6.92 
(m,  2H), 6.82–6.78 (m, 1H), 6.39 (d, J = 8.5 Hz, 1H), 6.36 (d, J = 8.0 Hz, 1H) 5.30 (s, 1H), 4.58–4.54 (m, 
1H), 3.70 (s, 3H), 3.20–3.11 (m, 1H), 3.06–2.99 (m, 2H), 2.74–2.69 (m, 1H), 2.59 (s, 3H), 2.46 (d, J = 
16.0 Hz, 1H); δC (100.6 MHz, CDCl3) 178.2 (C=N), 170.3 (C=O), 162.2 (C), 159.2 (C), 140.9 (C), 134.6 
(C), 131.7 (C), 129.4 (CH), 128.8 (CH), 127.1 (CH), 126.5 (CH), 123.3 (CH), 109.5 (CH), 62.1 (C), 60.0 
S39 
 
(CH), 53.5 (CH3), 38.0 (CH2), 37.6 (CH2), 29.1 (CH2), 16.8 (CH3); HRMS (ESI) m/z calcd for 
C20H19N3O2 (M + H)



































(9) Other heterocycle scope in the DIA spirocyclisation reaction 
 
(1'R*,10b'R*)-3,5-Dimethyl-5',6'-dihydro-2'H-spiro[pyrrole-2,1'-pyrrolo[2,1-a]isoquinolin]-
3'(10b'H)-one (major-14) and (1'R*,10b'S*)-3,5-dimethyl-5',6'-dihydro-2'H-spiro[pyrrole-2,1'-
pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (minor-14) 
 
    
 
major-14    minor-14 
 
General procedure A was followed using imine 6a (48 mg, 0.366 mmol), acid 12 (68 mg, 0.444 mmol), 
DIPEA (119 μL, 0.683 mmol) and T3P (353 mg of a 50% w/v solution in THF, 0.555 mmol), in CHCl3 (2 
mL) for 1 h at 70 °C. The unpurified reaction mixture contained a 14:1 mixture of 14 based on 
analysis by 1H NMR spectroscopy. Purification by flash column chromatography with CH2Cl2-MeOH 
(95:5) as eluent furnished 14 as a 13:1 mixture (61 mg, 62%). 
 
14: Brown oil, Rf  (95:5 CH2Cl2-MeOH) 0.30; νmax (thin film)/cm
−1 3052, 2921, 1687 (C=O), 1634, 1556, 
1459, 1419, 1305, 1265, 931, 700 cm-1; δH for major-14 (400 MHz, CDCl3) 7.15–7.02 (m, 3H), 6.63 (d, J 
= 8.0 Hz, 1H), 5.82 (d, J = 1.5 Hz, 1H), 5.45 (s, 1H), 4.52–4.43 (m, 1H), 3.33 (dd, J = 16.5, 1.0 Hz, 1H), 
3.07–2.93 (m, 2H), 2.83–2.78 (m, 1H), 2.29 (s, 3H), 2.24 (d, J = 16.5 Hz, 1H), 1.58 (d, J = 1.5 Hz, 3H); 
δC for major-14 (100.6 MHz, CDCl3) 175.1 (C=N), 170.7 (C=O), 167.0 (C), 133.1 (C), 132.5 (C), 129.0 
(CH), 127.1 (CH), 126.7 (2 x CH), 124.5 (CH), 85.2 (C), 59.3 (CH), 38.8 (CH2),  36.7 (CH2), 28.8 (CH2), 
18.9 (CH3), 13.2 (CH3); HRMS (ESI) m/z calcd for C17H18N2O (M + H)
+ 267.1492, found 267.1495 (−1.1 
ppm error).  
 
Diagnostic peaks for minor-14: δH (400 MHz, CDCl3) 6.39 (d, J = 7.5 Hz, 1H), 6.14 (d, J = 1.5 Hz, 1H), 








3'(10b'H)-one (major-15) and (1'R*,10b'S*)-3-methyl-5-phenyl-5',6'-dihydro-2'H-spiro[pyrrole-
2,1'-pyrrolo[2,1-a]isoquinolin]-3'(10b'H)-one (minor-15) 
 
   
major-15   minor-15 
 
General procedure A was followed using imine 6a (100 mg, 0.762 mmol), acid 12 (197 mg, 0.915 mmol), 
DIPEA (245 μL, 1.41 mmol) and T3P (725 mg of a 50% w/v solution in THF, 1.14 mmol), in CHCl3 (4 
mL) for 1 h at 70 °C. The unpurified reaction mixture contained a 5.6:1 mixture of 15 based on 
analysis by 1H NMR spectroscopy. Purification by flash column chromatography with EtOAc as 
eluent furnished 15 as a 13:1 mixture (192 mg, 77%). Some major-15 could be isolated by 
recrystallization (1:1 hexane-EtOAc) for characterisation. CCDC 1436465 contains the supplementary 
crystallographic data for this paper. The data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
15: Pale pink solid, mp 144–147 °C (CDCl3); Rf  (EtOAc) 0.20; νmax (thin film)/cm
−1 2975, 2934, 2913, 
2864, 1696 (C=O), 1627, 1424, 1409, 1361, 1310, 766, 747, 690, 667;   H (400 MHz, CDCl3) 8.03–
7.96 (m, 2H), 7.57–7.48 (m, 3H), 7.17–7.08 (m, 2H), 6.97 (ddd, J = 7.5, 7.5 , 2.2 Hz, 1H), 6.65 (d, J = 8.0 
Hz, 1H), 6.44-6.43 (m, 1H), 5.63 (s, 1H), 4.61–4.49 (m, 1H), 3.51 (dd, J = 16.1, 1.0 Hz, 1H), 3.15–2.97 
(m, 2H), 2.92–2.81 (m, 1H), 2.37 (d, J = 16.1 Hz, 1H), 1.71 (d, J = 2.0 Hz, 3H); δC (100 MHz, CDCl3) 
173.6 (C), 170.7 (C), 167.7 (C), 133.4 (C), 133.1 (C), 132.5 (C), 130.9 (CH), 128.9 (CH), 128.8 (CH), 
127.7 (2 x CH), 127.1 (CH), 126.8 (CH), 124.6 (CH), 123.6 (CH), 123.5 (CH), 86.0 (C), 59.7 (CH), 
39.2 (CH2), 36.8 (CH2), 28.8 (CH2), 13.6 (CH3); HRMS (ESI) m/z calcd for C22H20N2O (M + H)
+ 


















a]isoquinoline]-5-carboxylate major-17 and (1'R*,10b'S*)-ethyl 2,4-dimethyl-3'-oxo-3',5',6',10b'-
tetrahydro-2'H-spiro[pyrrole-3,1'-pyrrolo[2,1-a]isoquinoline]-5-carboxylate minor-17   
 
    
 
major-17    minor-17 
 
General procedure A was followed using imine 6a (34.0 mg, 0.259 mmol), acid 16 (70.0 mg, 0.311 
mmol), DIPEA (83.5 µL, 0.479 mmol) and T3P (124 mg of a 50% w/v solution in THF, 0.388 mmol), in 
CHCl3 (1.4 mL) for 1 h at 70 °C. The unpurified reaction mixture contained a 3.2:1 mixture of 17 
based on analysis by 1H NMR spectroscopy. Purification by flash column chromatography with 
EtOAc then EtOAc-MeOH (9.5:0.5) as eluent sequentially furnished minor-17 (11 mg, 13%) and major-
17 (41 mg, 47%). Total combined yield of minor-17 and major-17: 52 mg, 59%. 
 
Minor-17: Thin yellow film, Rf  (9.5:0.5 EtOAc/MeOH) 0.30; νmax (thin film)/cm
−1 3304, 2927, 1660, 
1633, 1436, 1269, 1208, 1174, 1088, 1025, 919, 773, 729;  H (400 MHz, CDCl3) 7.21–7.11 (m, 2H), 
7.11–7.05 (m, 1H), 6.47 (d, J = 7.5 Hz, 1H), 5.06 (s, 1H), 4.53–4.33 (m, 3H), 3.16–2.98 (m, 2H), 2.93–
2.79 (m, 1H), 2.87 (d, J = 17.0 Hz, 1H), 2.48 (s, 3H), 2.30 (d, J = 17.0 Hz, 1H), 1.78 (s, 3H), 1.42 (t, J = 
7.0 Hz, 3H); δC (100 MHz, CDCl3) 182.3 (C), 169.5 (C), 163.1 (C), 147.6 (C), 140.9 (C), 133.1 (C), 
132.0 (C), 129.3 (CH), 127.9 (CH), 127.8 (CH), 123.4 (CH), 67.7 (C), 61.1 (CH2), 57.9 (CH), 37.3 
(CH2), 36.9 (CH2), 28.3 (CH2), 17.2 (CH3), 14.3 (CH3), 11.3 (CH3); HRMS (ESI) m/z calcd for 
C20H22N2O3 [M + H]
+ 339.1703, found 339.1698 (+1.5 ppm error).  
 
 Major-17: Yellow oil, Rf  (9.5:0.5 EtOAc/MeOH) 0.20; νmax (thin film)/cm
−1 3301, 2980, 2930, 1655, 
1435, 1270, 1213, 1174, 1092, 910, 728;   H (400 MHz, CDCl3) 7.20–7.09 (m, 2H), 7.05 (dd, J = 7.0, 
7.0 Hz, 1H), 6.43 (d, J = 7.5 Hz, 1H), 5.16 (s, 1H), 4.52–4.45 (m, 1H), 4.36–4.25 (m, 2H), 3.15–2.95 (m, 
2H), 2.94 (dd, J = 17.0, 1.0 Hz, 1H), 2.89–2.80 (m, 1H), 2.50 (s, 3H), 2.36 (d, J = 17.0 Hz, 1H), 1.80 (s, 
3H), 1.34 (t, J = 7.0 Hz, 3H); δC (100 MHz, CDCl3) 180.06 (C), 169.5 (C), 163.0 (C), 151.2 (C), 140.1 
(C), 133.1 (C), 131.5 (C), 129.2 (CH), 127.8 (CH), 127.4 (CH), 123.8 (CH), 67.4 (C), 60.8 (CH 2), 
59.2 (CH), 37.6 (CH2), 37.3 (CH2), 28.3 (CH2), 16.2 (CH3), 14.3 (CH3), 11.1 (CH3); HRMS (ESI) m/z 
calcd for C20H22N2O3 [M + H]













(10) Procedures for the modification of spirocycles 8a and 8g 
 
(1'S*,2S*,10b'R*)-2-Methyl-5',6'-dihydro-2'H-spiro[indoline-3,1'-pyrrolo[2,1-a]isoquinolin]-






Using general procedure B, NaBH4 (50 mg, 1.32 mmol) and spiroindolenine 8a (100 mg, 0.331 mmol) in 
MeOH (5 mL) at reflux for 3.5 h gave the crude product. Purification by flash column chromatography 
using EtOAc-hexane (9:1) as eluent gave spiroindoline 18 (81 mg, 81%) as a cream solid, mp 229–
231 °C; Rf  (EtOAc) 0.50; νmax (thin film)/cm
−1 3318 (NH), 3058, 2924, 1682 (C=O), 1606, 1578, 1459, 
1305, 1143, 909, 727; H (400 MHz, CDCl3) 7.52 (d, J = 7.5 Hz, 1H), 6.97–6.89 (m, 3H), 6.83 (ddd, J = 
7.5, 7.5, 1.0 Hz, 1H), 6.80–6.78 (m, 1H), 6.46 (d, J = 8.0 Hz, 1H), 6.43 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 
5.18 (s, 1H), 4.52–4.47 (m, 1H), 4.05 (br s, 1H), 4.01 (q, J = 7.0 Hz, 1H), 2.97–2.81 (m, 3H), 2.73 (dd, J 
= 16.5, 1.0 Hz, 1H), 2.69-2.65 (m, 1H), 1.64 (d, J = 7.0 Hz, 3H); C (100.6 MHz, CDCl3) 170.8 (C=O), 
149.6 (C), 134.3 (C), 133.2 (C), 132.9 (C), 128.5 (CH), 128.2 (CH), 126.7 (CH), 126.4 (CH), 125.7 (CH), 
122.4 (CH), 119.2 (CH), 109.4 (CH), 62.2 (CH), 61.8 (CH), 53.9 (C), 44.8 (CH2), 37.3 (CH2), 29.3 (CH2), 
15.7 (CH3); HRMS (ESI) m/z calcd for C20H20N2O (M + H)
+ 305.1648, found 305.1645 (+1.1 ppm error). 
18 was recrystallized from EtOAc and an X-ray crystal structure obtained. CCDC 1436401 contains the 
supplementary crystallographic data for this paper. The data can be obtained free of charge from The 












Using general procedure B, NaBH4 (52 mg, 1.39 mmol) and spiroindolenine 8g (100 mg, 0.347 mmol) in 
MeOH (5 mL) at reflux for 3.5 h gave the crude product. Purification by flash column chromatography 
using EtOAc as eluent gave spiroindoline 19 (87 mg, 87%) as a cream solid, mp 211–213 °C; Rf  (EtOAc) 
0.30; νmax (thin film)/cm
−1 3330 (NH), 2924, 2855, 1675 (C=O), 1606, 1487, 1459, 1415, 1306, 909, 729; 
H (400 MHz, CDCl3) 7.33–7.31 (m, 1H), 7.01–6.93 (m, 3H), 6.85 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.77–
6.75 (m, 1H), 6.47 (d, J = 8.0 Hz, 1H), 6.44–6.40 (m, 1H), 5.04 (s, 1H), 4.51–4.47 (m, 1H), 4.09 (d, J = 
10.0 Hz, 1H), 3.35 (d, J = 10.0 Hz, 1H), 2.98–2.84 (m, 4H), 2.71–2.67 (m, 1H); C (100.6 MHz, CDCl3) 
171.3 (C=O), 150.6 (C), 134.1 (C), 132.9 (C), 131.5 (C), 128.7 (CH), 128.4 (CH), 126.7 (CH), 126.0 
S45 
 
(CH), 125.6 (CH), 122.4 (CH), 118.8 (CH), 109.5 (CH), 68.2 (CH), 57.6 (CH2), 52.4 (C), 46.2 (CH2), 
35.1 (CH2), 29.2 (CH2); HRMS (ESI) m/z calcd for C19H18N2O (M + H)
+ 291.1492, found 291.1486 (+1.9 









Using general procedure C, LiAlH4 (76 mg, 2.00 mmol) and spiroindoline 18 (153 mg, 0.50 mmol) in dry 
THF (15 mL) under Ar at reflux for 2.5 h gave the crude product. Purification by flash column 
chromatography EtOAc as eluent gave spiroindoline 20 (110 mg, 75%) as a white solid, mp 141–143 °C; 
Rf  (EtOAc) 0.45; νmax (thin film)/cm
−1 3356 (NH), 2981, 2897, 2804, 1604, 1467, 1330, 935, 762, 556; 
H (400 MHz, CDCl3) 7.48 (d, J = 7.5 Hz, 1H), 7.02 (dd, J = 7.5, 1.0 Hz, 1H), 6.96–6.91 (m, 2H), 6.89–
6.81 (m, 2H), 6.54 (d, J = 7.5 Hz, 1H), 6.49 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 4.02 (q, J = 7.0 Hz, 1H), 3.64 
(s, 1H), 3.30–3.22 (m, 2H), 3.14–3.06 (m, 1H), 2.67 (dd, J = 16.0, 4.0 Hz, 1H), 2.60–2.46 (m, 3H), 1.98–
1.92 (m, 1H), 1.50 (d, J = 7.0 Hz, 3H); C (100.6 MHz, CDCl3) 150.0 (C), 136.3 (C), 136.1 (C), 135.3 (C), 
128.1 (CH), 127.2 (CH), 127.1 (CH), 125.5 (CH), 125.2 (CH), 125.0 (CH), 118.1 (CH), 108.8 (CH), 69.4 
(CH), 63.9 (CH), 56.7 (C), 52.2 (CH2), 49.9 (CH2), 41.6 (CH2), 29.2 (CH2), 16.1 (CH3); HRMS (ESI) m/z 
calcd for C20H22N2 (M + H)























Using general procedure C, LiAlH4 (78 mg, 2.04 mmol) and spiroindoline 19 (148 mg, 0.51 mmol) in dry 
THF (15 mL) under Ar at reflux for 2.5 h gave the crude product. Purification by flash column 
chromatography EtOAc as eluent gave spiroindoline 21 (94 mg, 67%) as a yellow oil, Rf  (EtOAc) 0.10; 
νmax (thin film)/cm
−1 3291 (NH), 2923, 2790, 1638, 1604, 1577, 1484, 1264, 1026, 731, 701; H (400 
MHz, CDCl3) 7.04 (d, J = 8.0 Hz, 1H), 7.00–6.97 (m, 2H), 6.90 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.83 (dd, 
J = 7.5, 7.5 Hz, 1H), 6.79–6.77 (m, 1H), 6.60 (d, J = 8.0 Hz, 1H), 6.47 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 
4.01 (d, J = 9.5 Hz, 1H), 3.71 (d, J = 9.5 Hz, 1H), 3.54 (s, 1H), 3.31–3.12 (m, 3H), 2.79–2.75 (m, 1H), 
2.65–2.56 (m, 2H), 2.29 (ddd, J = 13.0, 9.5, 8.0 Hz, 1H), 2.17 (ddd, J = 13.0, 8.0, 2.5 Hz, 1H); C (100.6 
MHz, CDCl3) 150.9 (C), 135.7 (C), 135.4 (C), 135.0 (C), 128.4 (CH), 127.2 (CH), 126.0 (CH), 125.7 
(CH), 125.2 (CH), 125.0 (CH), 118.8 (CH), 109.1 (CH), 73.1 (CH), 60.7 (CH2), 55.0 (C), 52.7 (CH2), 
49.4 (CH2), 42.7 (CH2), 29.4 (CH2); HRMS (ESI) m/z calcd for C19H20N2 (M + H)
+ 277.1699, found 









MeMgBr (3M in Et2O, 0.59 mL, 1.77 mmol) was added to a stirred solution of spiroindolenine 8g (170 
mg, 0.59 mmol) in dry THF (7 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 6 h, 







the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organics were dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography using EtOAc-hexane (9:1) as eluent gave the spiroindoline 23 (112 mg, 62%) as an 
orange solid, mp 141-143 °C; Rf (EtOAc) 0.45; νmax (thin film)/cm
−1 3319 (NH), 3051, 2926, 1676 
(C=O), 1606, 1459, 1415, 1305, 1264, 730, 701; H (400 MHz, CDCl3) 7.38–7.36 (m, 1H), 7.02–6.95 (m, 
2H), 6.93–6.91 (m, 1H), 6.83 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.76 (d, J = 7.5 Hz, 1H), 6.43–6.39 (m, 2H), 
4.94 (s, 1H), 4.49–4.45 (m, 1H), 4.32 (q, J = 6.5 Hz, 1H), 3.05 (dd, J = 16.0, 1.0 Hz, 1H), 2.96–2.82 (m, 
2H), 2.71–2.64 (m, 1H), 2.52 (d, J = 16.0 Hz, 1H), 1.31 (d, J = 6.5 Hz, 3H); C (100.6 MHz, CDCl3) 
171.8 (C=O), 148.9 (C), 134.6 (C), 132.8 (C), 130.7 (C), 128.5 (CH), 128.3 (CH), 126.6 (CH), 126.2 
(CH), 125.7 (CH), 122.7 (CH), 118.4 (CH), 109.2 (CH), 67.6 (CH), 61.3 (CH), 56.7 (C), 40.4 (CH2), 37.0 
(CH2), 29.3 (CH2), 19.5 (CH3); HRMS (ESI) m/z calcd for C20H20N2O (M + H)
+ 305.1648, found 









A flask was charged with spiroindolenine 8g (100 mg, 0.35 mmol) and pyrrole (218 μL, 3.15 mmol). 
AcOH (2.5 mL) was added and the reaction was stirred for 16 h. Sat. NaHCO3(aq) (10 mL) and CH2Cl2 (10 
mL) were carefully added to the reaction and the layers were separated. The aqueous layer was extracted 
with CH2Cl2 (2 x 10 mL) and the combined organics were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on silica using EtOAc as 
eluent gave the spirocyclic product 22 (107 mg, 86%) as a yellow solid, mp 234–236 °C; Rf  (EtOAc) 0.25; 
νmax (thin film)/cm
−1 3326 (NH), 3180, 2927, 2851, 1655 (C=O), 1607, 1484, 1467, 1249, 969, 729; H 
(400 MHz, CDCl3) 10.89 (s, 1H), 7.32 (d, J = 7.5 Hz, 1H), 7.10–6.98 (m, 3H), 6.79 (ddd, J = 7.5, 7.5, 1.0 
Hz, 1H), 6.75–6.73 (m, 1H), 6.46 (d, J = 7.5 Hz, 1H), 6.43 (d, J = 7.5 Hz, 1H), 6.26 (ddd, J = 7.5, 7.5, 1.0 
Hz, 1H), 6.18 (d, J = 2.5 Hz, 1H), 6.07–6.05 (m, 1H), 6.03–6.02 (m, 1H), 5.42 (d, J = 2.5 Hz, 1H), 5.08 (s, 








1H), 1.88 (d, J = 16.5 Hz, 1H); C (100.6 MHz, CDCl3) 170.1 (C=O), 150.2 (C), 134.9 (C), 134.0 (C), 
131.3 (C), 130.6 (C), 128.9 (CH), 127.7 (CH), 126.3 (CH), 126.2 (CH), 125.8 (CH), 122.3 (CH), 117.6 
(CH), 117.1 (CH), 108.4 (CH), 107.5 (CH), 106.3 (CH), 64.0 (C), 63.7 (NCH), 57.1 (C), 43.0 (CH2), 36.5 
(CH2), 29.0 (CH2); HRMS (ESI) m/z calcd for C23H21N3O (M + H)

































(11) 1H and 13C Spectra  
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12) 3-Dimensional shape analysis of spirocyclic products and FDA approved drugs 
3D structures were generated Pipeline Pilot 8.5.0.200, 2011, Accelrys Software Inc. Prior to conformer 
generation a wash step was performed, which involved ionising the molecule at pH 7.4, adding explicit 
hydrogens and outputting the canonical tautomer. Conformers were generated using the BEST method in 
Catalyst with a maximum relative energy threshold of 20 kcal mol-1. These conformations were then 
minimised using 1000 steps of Steepest Descent with a RMS gradient tolerance of 3 and 200 steps of 
Conjugate Gradient with an RMS gradient tolerance of 0.1. Minimisation was performed using the 
CHARMm forcefield with Momany-Rone partial charge estimation and a Generalised Born implicit 
solvent model. The lowest energy conformer was selected. The generated conformations were used to 
generate the three Principal Moments of Inertia (I1, I2 and I3) which were then normalised by dividing 
the two lower values by the largest (I1/I3 and I2/I3) using Pipeline Pilot built-in components.  
Principal moments of inertia (PMI) about the principal axes of a molecule were calculated according to 
the following rules:  
1. The moments of inertia are computed for a series of straight lines through the centre of mass.    
2. Distances are established along each line proportional to the reciprocal of the square root of I on 
either side of the centre of mass. The locus of these distances forms an ellipsoidal surface. The principal 
moments are associated with the principal axes of the ellipsoid.    
3.    If all three moments are equal, the molecule is considered to be a symmetrical top. If no moments 
are equal, the molecule is considered to be an unsymmetrical top.    









PMI plot of FDA approved drugs 
The PMI plot of 1439 FDA approved small molecule drugs is shown in Figure 1. The compound data was 
taken from the DrugBank database.35 23% of the compounds are found within the (NPR1 + NPR2) > 1.2 
region i.e. in the blue triangle (Figure 1). 
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